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ABSTRACT
A total of 402 bovine embryos, non-surgically collected on 
day 6.5-7.5 after estrus, were utilized in evaluation of fluorescein 
diacetate (FDA) for estimating embryo viability In vitro and to inves­
tigate the effect of Bovine Viral Diarrhea (BVD) Virus on embryonic 
development during in vitro culture. Fluorescent assessment, using UV 
microscopy (440-480 nm) of embryos after staining in FDA (2.5 pg/ml 
phosphate buffered saline: PBS), was found to be a rapid, non-toxic and 
accurate method for evaluation of viability. Embryos with highest 
fluorescent scores (Score = 4) prior to culture developed at the 
highest rate (95.7%), while embryos with no fluorescence (score = 0) 
did not develop. Significant correlations were found between morpho­
logical grading and fluorescent scores (r = .71), although FDA was more 
sensitive in estimating positive development.
The investigation of the effect of BVD virus on development 
of bovine embryos was divided into three studies: (1) BVD virus
cultured with live and dead embryos each with and without zona pellu­
cida (four treatments), (2) Micro-injection of BVD virus directly into 
the blastocele of blastocysts and (3) transfer of BVD virus-exposed 
embryos into recipient cows. In the first study, live embryos (with 
and without a zona pellucida) assessed by FDA, developed at normal 
rates when exposed to BVD virus, showing that embryonic development 
was independent of the zona pellucida. Virus isolation from
xiii
sonificated embryos along with attempts to measure the uptake of virus 
was unsuccessful. Transmission electron microscopy (TEM) revealed BVD 
virus-like particles beneath the zona pellucida of live embryos 
indicating that the virus penetrated the zona pellucida. TEM 
evaluation of live embryos without zona pellucida also revealed BVD 
virus-like structures, while no structures resembling the BVD virus 
were found in dead embryos with and without zona pellucida. Micro­
injection of BVD virus (Study 2) did not reduce in vitro development 
(91.7%) as compared with control medium-injected blastocysts (85.0%) 
or non-injected controls (88.3%). In vitro development was 75 and 71 
percent for control and BVD virus-exposed embryos, respectively (Study 
3). BVD serum neutralizing antibodies of recipient females did not 
change after transfer of either control and BVD virus-exposed embryos, 
indicating that either the virus was not transmitted in the embryos 
or medium or that the concentration of virus was not high enough to 
stimulate the immunological system of the recipient females. Preg­
nancy rates were 20.0 and 13.3 percent for control and BVD virus- 
exposed embryos at 65 days post-transfer. Embryonic mortality was 
higher in recipients transferred with BVD virus-exposed embryos (5 
of 30, 16.7%) compared to controls (3 of 30, 10%); however, this dif­
ference was not statistically significant.
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INTRODUCTION
The beef cattle industry is a multi-million dollar business, 
and like any other business it must concern itself with making a 
profit. In the economic production of beef cattle, every female 
should produce living offspring and raise them to market weight.
Every calf dying before reaching market weight due to abortion or 
disease, or every animal retarded due to mismanagement, represents 
the loss of a sizeable sum of money to the producer. Therefore, the 
goal of the efficient producer is to reduce the number of losses 
from conception to consignment.
Embryo transfer has become a major management practice in 
the beef and dairy industry, providing more calves from selected 
matings of specific dams and sires. Improved embryo collecting and 
superovulation has enabled more trained technicians to provide embryo 
transfer services at a reduced cost to cattlemen. Skill involved 
in predicting fertility of embryos has not developed at a sufficient 
rate to compliment other advancements in embryo transfer. This is 
likely due to the inadequacies of grading embryos morphologically. 
Therefore, a preliminary study was designed to evaluate the use of 
fluorescein diacetate for use in embryo viability scoring.
Bovine virus diarrhea (BVD) is an acute or chronic, con­
tagious and infectious disease of cattle. It is characterized by
1
fever, nasal discharge, coughing, profuse watery diarrhea, rapid 
dehydration and emaciation. The disease is considered to be wide­
spread, with up to 56 percent of adult cattle having antibodies to 
the virus. The greatest loss to beef cattle producers due to BVD 
infection are those dealing with inapparent infection in the herd. 
These losses are often related to reproductive failure such as 
infertility, fetal absorption, fetal mummification, abortion and 
embryonic mortality.
Previous research has demonstrated that the intrauterine 
location of the BVD virus could interfere with normal development 
of preimplantation bovine embryos. However, in that study it was 
not possible to ascertain whether the effect was due primarily to 
the BVD virus, or whether the virus altered the uterine environment 
to produce the effects of the BVD virus on preimplantation bovine 
embryos using _in vitro techniques.
CHAPTER I
THE USE OF FLUORESCEIN DIACETATE (FDA) TO 
ASSESS VIABILITY OF BOVINE EMBRYOS IN VITRO
Introduction
The commercial bovine embryo transfer industry has enjoyed 
success in the last few years due largely to technological advances 
in embryo collection, transfer techniques and in improved super­
ovulation methods (Schneider et al., 1980). Advances in embryo 
culture and grading techniques have also contributed to the overall 
growth of the industry.
Embryo grading is an important decision in embryo transfer 
because of the need to predict if the embryo is viable and has the 
developmental capacity to establish a pregnancy. Embryo grading is 
usually assigned to trained observers who use a simple subjective 
system of qualifications. The embryo grading system is based on 
morphological assessments of the cellular mass and to a lesser extent, 
of the zona pellucida (Shea, 1981). In general, bovine embryos are 
considered normal when blastomeres are symmetrical and the develop­
mental stage of the embryo coincides with the day of estrus on which 
the embryo was collected (appendix table 1). Poor quality embryos 
have asymmetrical cell masses, extraneous degenerate cells or, in 
the case of blastocysts have a collapsed blastocele (Trounson et al.,
3
41976; Shea, 1976; Wishart, 1977; Schneider et al., 1980; Shea, 1981). 
Although embryo grading has been described by Church and Shea (1976) 
as being a difficult and frustrating process requiring practical 
experience, it is a good predictor of pregnancy rates. Schneider 
et al. (1980), citing results of a large commercial bovine embryo 
transfer facility, reported a higher pregnancy rate after transfer 
of good embryos (70%) than poor embryos (55%). Shea (1981) also 
reported similar results, with Grade 4 embryos (Grade 4 = best) 
yielding a 71 percent pregnancy rate while Grade 2 embryos resulted 
in a pregnancy rate of 44 percent. Elsden et al. (1978) found simi­
lar results when they classified bovine embryos according to their 
morphology as excellent, good, fair and poor; pregnancy rates were 
63, 58, 31 and 12 percent, respectively. In each of these studies, 
embryos of poor quality were able to develop after transfer and 
establish pregnancies, indicating that some variability existed in 
the technique. Variability in the assessment of viability is open 
to misinterpretation by the fact that particular donors yield embryos 
of poor quality grade while their pregnancy rate is high when suit­
able recipients are used. On the other hand, some donors produce 
high quality embryos but yield a low pregnancy rate.
The lack of precision in the technique of embryo grading 
using morphological criteria has prompted researchers to develop 
additional tests for evaluating embryo viability. Assays of via­
bility by assessing metabolic activity have been used for rabbit
5embryos (Anderson and Foote, 1974, 1975). These tests require long 
incubation periods and render the embryo nontransferable after the 
result of the test. Renard et al. (1977) worked with an in vitro 
test of energy sources and enzyme qualification of the holding medium 
of day 10 blastocysts to predict viability. Another simpler test of 
embryo viability is to culture the embryos in question in a medium 
of known compatibility. Bovine embryos often respond favorably to 
culture (Wright et al., 1976) and still result in a high pregnancy 
rate (Shea, 1981).
Rotman and Papermaster (1966) introduced a test of viability 
based upon a fluorochromatic principle. These authors found that 
certain nonfluorescent fatty-acid esters of fluorescein are hydro­
lyzed in living cells by esterases yielding free fluorescein. The 
fluorescein accumulates intracellularly and fluoresces upon exci­
tation at wave lengths between 440 and 480 nm. The model described 
by Rotman and Papermaster (1966) was that 3'6' diacetyl-fluorescein 
(FDA), being non-polar, can readily pass into the cell where it is 
hydrolyzed by esterases yielding polar fluorescein. The polar 
fluorescein cannot readily cross the cell membrane and therefore 
accumulates intracellularly. The test is a measure of both esterase 
enzyme activity and membrane integrity. Results utilizing the FDA 
test were very encouraging because of its simple, rapid and non-toxic 
procedure for embryos. Leibo and Mazur (1978) utilized the FDA test 
to evaluate survival of mouse embryos after freezing and thawing. 
Jackowski (1977) showed a high correlation (r = .96) between the
6fluorescence of the embryo and its ability to develop in culture 
after freezing. Evaluation of the viability of bovine embryos 
(Schilling and Dopke, 1978; Schilling et al., 1979; Church and Rains, 
1980; Looney et al., 1981; Renard et al., 1982), and of mouse embryos 
(Mohr and Trouson, 1980) has been demonstrated by fluorescence micro­
scopy with FDA. Observations by these workers were very encouraging, 
but more research is needed to be able to establish the embryo's 
ability to develop in culture or in vivo.
The specific objectives of this experiment were:
1. To investigate the relationship between morphological 
assessments and fluorometric assessments of stained 
embryos at pre-culture and post-culture intervals.
2. To determine the relationship between fluorometric
assessment of stained embryos and their subsequent 
development in vitro.
3. To determine if the FDA viability test can be utilized
as a practical embryo transfer technique.
4. To compare the FDA viability test with subjective
grading assessments to determine if one or both can 
be used with in vitro embryo culture experiments.
7Materials and Methods
Experimental Animals
A total of 24 multiparous Gelbvieh crossbred cows served as 
donors for the embryos used in this study. The cows ranged in body
weight from 430 to 560 kg at the time of collection. The cows were
maintained on common bermudagrass or dallisgrass pasture lots at the 
St. Gabriel Experiment Station, St. Gabriel, Louisiana, and were fed 
4.5 kg of a 14 percent protein high fiber ration per head daily. The
study was conducted during the months of May through August. Ample
shade was provided to reduce thermal stress during the period of the 
study. A penile-deflected teaser bull fitted with a chin-ball 
marking harness'*' was used to aid in twice daily estrus detection.
Superovulation of Donors
The superovulatory regimen for this experiment consisted of
intramuscular (IM) injections of 5 mg of follicle stimulating hor- 
2
mone (FSH) twice daily at 12 h intervals. Donors began super­
ovulatory treatment on days 9 through 12 (estrus = day 0) but only
after rectal palpation confirmed the presence of a corpus luteum
3
on one or both ovaries. A 35 mg dose of prostaglandin F2 a
^Crocket and Kelly, Inc., Broomfield, Colorado.
2 R
FSH-P , Burns-Biotec, Omaha, Nebraska.
3 R
Lutalyse (dinoprost tromethamine), Upjohn Co., Kalamazoo,
Michigan.
8was administered IM 48 h after the initial FSH injection to induce 
luteolysis. Estrus was expected within 48 h after PGF2 a injection. 
Donors received a total of either 40 or 45 mg of FSH during super­
ovulation treatments. When estrus was detected FSH injections were 
discontinued and cows were artifically inseminated (Al) with frozen- 
thawed semen starting 12 hours after the onset of estrus. Semen used 
in this study was from one collection of a single Gelbvieh bull. Two 
units of semen were inseminated at 12 h, 24 h and 36 h after onset 
of estrus.
Embryo Collection Technique
Donor cows were returned to separate pasture lots after 
superovulation and breeding requirements were fulfilled to avoid 
the stress of handling as routine superovulation procedures con­
tinued on herd mates. Non-surgical embryo collection techniques 
were employed in this study 7.0 to 7.5 days after estrus (estrus =
day 0). Donors were initially prepared for collection by admin-
4
istration of 10 or 15 mg Acepromazine IM. Cows were also given an
epidural injection of 3 to 5 ml of Carbocaine^ to reduce rectal
contractions during the collection process. The donors were then
6
placed in lateral recumbency on a tilting stock table at approxi­
mately 38-40° angle. After cleansing the external genitalia with
^Acepromozine, Fort Dodge Laboratories, Fort Dodge, Iowa. 
^Carbocaine, Winthrop Laboratories, New York, New York. 
^Tilting Stock Table, Powder River Co., Provo, Utah.
R 7fresh water, a Foley catheter was passed through the cervical canal, 
the inflatable cuff was seated at the internal os of the cervix, and 
the cuff filled with 5 to 7 ml of physiological saline. Approximately
Q
420 ml of sterile Dulbecco's phosphate buffered saline (PBS) con-
q
taining 2 percent fetal calf serum (FCS) and 1 percent antibiotic-
antimycotic solution consisting of 100 IU Penicillin, 100 yg Strep-
10
tomycin and .25 yg Fungizone (appendix table 2) were infused in 
60 to 120 ml increments utilizing a sterile tubing with luer-lock 
and sterile 60 ml syringes. PBS was infused while rectal manipula­
tion of the uterus was performed to insure that the medium flowed 
throughout each uterine horn simultaneously. Medium was recovered 
from the uterus into the empty 60 ml syringe and a replacement 
syringe filled with fresh medium was inserted to keep a closed 
system. The flushing procedure continued until all of the medium 
was infused and recovered from the uterus. In cases of poor recovery 
of the medium from the uterus, 80 IU oxytocin"^ was administered 
intravenously (IV) into the coccygeal vein to induce uterine con­
tractions and evacuation of any unrecovered medium from the uterus.
7 R
Foley catheter, C. R. Bard, Inc., Murry Hill, New Jersey.
g
Dulbecco's Phosphate Buffered Saline, Grand Island Biologi­
cal Co., Grand Island, New York.
9
Fetal Calf Serum, Grand Island Biological Co., Grand Island,
New York.
■^Antibiotic-Antimycotic Solution, Grand Island Biological Co., 
Grand Island, New York.
"^Oxytocin, The Butler Company, Columbus, Ohio.
10
induce uterine contractions and evacuation of any unrecovered medium 
from the uterus.
Embryo Handling
Immediately after collection procedures the recovered media
12was placed in sterile containers (100 x 15 mm graded petri-dish )
and examined by two observers using a stereomicroscope. When an
embryo was located, it was aspirated by a sterile handling pipette
13
and transferred to a holding dish (35 x 10 mm) containing holding 
medium (PBS with 20 percent FCS and the standard concentration of 
antibiotics and antimycotic). After each petri-dish was examined 
by both observers, the embryos were evaluated and their number 
recorded. Embryos remained in the holding medium at room temperature 
(24-28°C).
FDA Viability Test
A stock solution of 5 mg of fluorescein diacetate^ (3'6T 
diacetyl fluorescein; 5 mg/ml in acetone) was prepared and stored 
in an aluminum covered glass vial in a dessicator at -20°C. Imme­
diately prior to use, the staining solution (2.5 pg/ml) was prepared 
by adding 0.5 pi stock solution per ml PBS. Embryos were incubated
12
Quebec Grid Petri-Dish 100 x 15 mm, Lab Tek, Products, 
Division of Miles Laboratory, Naperville, Illinois.
13Falcon Petri-Dish 35 x 10 mm, Falcon Division of Becton- 
Dickinson, Oxnard, California.
14
Fluorescein Diacetate, Sigma Chemical Co., St. Louis,
Missouri.
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in this staining solution for 60 seconds at room temperature 
(24-28°C). Embryos were then transferred to a microconcavity slide 
containing holding medium for microscopic evaluation. The embryos 
were examined at 100 X with an Olympus BH photomicroscope with phase- 
contrast optics. All observations under ultraviolet (UV) light were 
carried out using the Olympus combination of filters (Olympus RFL) 
which contained an excitor filter BG-12, chromatic beam splitter 
DM-500 + 0-515 and a barrier filter 0515. Fluorescence was evaluated 
by subjective measurements at 10 to 20 seconds of UV observation of 
each embryo. Fluorescence was scored in the following manner: Score
4, very bright and uniform fluorescence; Score 3, bright and uniform 
fluorescence; Score 2, pale and uniform or patchy fluorescence within 
cells; Score 1, pale, often patchy fluorescence within cells just 
detectable visually and Score 0, no fluorescence visible.
Morphological Classification Assessments of Embryos
Embryos were classified morphologically as follows. Unfer­
tilized ova were characterized by a thick zona pellucida and the 
appearance of a smooth edge surrounding the cellular mass. Two-cell 
through the 32-cell stage embryos were classified by actually coun­
ting the number of distinct blastomeres within the zona pellucida. 
Morulae are embryos containing more than 32 blastomeres and had not 
yet coalesced to form a compact mass. Advanced morulae were dis­
tinguished from a morula primarily on the basis that the cellular 
mass had coalesced but not developed a blastocoele. Early
12
blastocysts were embryos exhibiting a small blastocoele with the 
appearance of a 'signet ring.' Blastocysts were identified by the 
blastocoele which had expanded to fill at least one-half of the entire 
cell mass within the zona pellucida. Expanded blastocysts were char­
acterized by a fully expanded blastoceolic cavity which filled the 
entire zona pellucida. Hatched or Hatching blastocysts were iden­
tified as those which had shed the zona pellucida completely or were 
undergoing this process.
Morphological Grading
Morphological assessments were graded in the following manner. 
Grade 1, cellular masses symmetrical, developmental stage correct for 
day post-estrus on which collection occurred, blastomeres non-pyknotic; 
if blastocysts are encountered the blastocelic cavity must not be 
collasped; Grade 2, extruded blastomeres present, cellular mass par­
tially asymmetrical and partially pyknotic; Grade 3, cell mass irreg­
ular, asymmetrical and partially pyknotic, extruded blastomeres not 
attached to functional cell mass, cytoplasm appeared to be granular 
and freely movable when embryo was moved; extruded cells were pyknotic 
giving the cellular mass a dark appearance; Grade 4, embryos entire 
cellular mass pyknotic, cytoplasm was loosened and had no integrity 
within the blastomeres, zona pellucida might appear flat indicating 
advanced degeneration. Unfertilized ova (UFO) were routinely given 
a Grade of 0.
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Embryo Culture
Embryos and ova were cultured individually in 24-well 
covered disposo-trays^ for twelve hours. Each embryo or ova was 
held in 2 ml of holding medium (appendix table 3). The culture 
media was filtered through a 0.22 pm millipore filter^ immediately 
before use in the culture system. The dispo-tray was maintained in 
a humidified air atmosphere at 37°C during the culture period.
Upon the conclusion of the 12 h culture period the embryos were 
transferred to sterile microconcave slides containing holding 
medium for post-culture evaluation. Post-culture evaluation was 
performed using criteria previously described for pre-culture embryos.
Statistical Analysis
Each embryo and ova was treated with the FDA staining solu­
tion and observed by one observer using a double-blind approach. 
Embryos and ova were individually evaluated and cultured throughout 
the experiment. The percentages of embryos and ova developing in 
culture as assessed by pre-culture and post-culture morphological 
grade and fluorescence were not subjected to statistical analysis, 
but were utilized to portray trends in discussing the data. Simple 
correlations (Sail, 1979, Statistical Analysis Systems) were obtained 
on data from pre-culture and post-culture morphological grade and
^Linbro Multi-dish Disposo-Trays, Linbro Scientific Co.,
Inc., New Haven, Connecticut.
^Acrodisc^, Gelman Sciences, Inc., Ann Arbor, Michigan.
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fluorescence and resulting development in vitro. Least squares 
analysis of variance was performed using the general linear model 
procedure of the Statistical Analysis System (Goodnight, 1979). 
The dependent variables utilized in the analysis were the embryo 
viability indicators, morphological grade, and fluorescence. The 
independent variables were culture time and result of development 
of the embryos in culture, as well as the interaction of culture 
time by result of development.
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Results and Discussion
A total of 162 embryos and ova were non-surgically collected 
from 24 superovulated Gelbvieh crossbred cows. A mean of 6.75 
embryos and ova were collected per donor. The mean recovery rate 
in this experiment was lower than that collected from 519 super­
ovulated donors (9.95 ova/donor) as reported by Schneider et al. 
(1980), but is higher than the 4.1 ova/donor previously reported by 
Looney et al. (1981).
In table 1, the 162 embryos and ova are classified by pre­
culture morphological classification. A total of 38 unfertilized 
ova (UFO) were present, which accounted for 23.5 percent of the 
total embryos and ova collected. The number of unfertilized ova 
collected from superovulated donor cattle is variable and can be 
attributed to semen quality, insemination interval and individuality 
of donors (Moore, 1975; Nelson et al., 1976; Shea et al., 1976). 
Schneider et al. (1980) reported 18.0 percent unfertilized ova from 
a total of 5169 embryos and ova collected and Looney et al. (1981) 
found similar results with 21.5 percent unfertilized ova from a 
total of 489 embryos and ova collected. A relatively small number 
of embryos of the two-cell (2 Cell), four-cell (4 Cell), sixteen-cell 
(16 Cell) and thirty-two cell (32 Cell); (n = 2, 2, 1 and 4, respec­
tively) stages were collected from the 24 donors. Embryos in these 
morphological stages are considered abnormal when they were found in 
flushings from donors on day 7 of diestrus (Seidel et al., 1980).
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TABLE 1. FREQUENCIES OF MORPHOLOGICAL CLASSIFICATIONS
OF EMBRYOS BEFORE CULTURE
Morphological classification No. Percent of total
Unfertilized Ova 38 23.5
Two Cell 2 1.2
Four Cell 2 1.2
Sixteen Cell 1 0.6
Thirty-two Cell 4 2.5
Morula 63 38.9
Advanced Morula 9 5.6
Early Blastocyst 21 12.9
Blastocyst 1 0.6
Expanded Blastocyst 21 12.9
Total 162 100.0%
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The combination of all of these abnormal embryos accounted for only
5.5 percent of the total embryos and ova collected. The morula (MOR) 
morphological classification was the embryo stage represented most 
frequently (n = 63). This observation is in agreement with Seidel
et al. (1980) who reported that the morula or tight (advanced) morula 
were normally found on 5-7 days of the donor's estrous cycle. MOR 
and advanced morula (AMOR) classifications combined accounted for
44.5 percent of the total embryos and ova collected. The combined 
morphological classification of all blastocysts accounted for 26.4 
percent of the total embryos and ova collected. This morphological 
classification was sub-divided into early blastocyst (ERB; n = 21), 
blastocyst (BLA; n = 1) and expanded blastocyst (EXB; n = 21) and 
were found at frequencies of 12.9, .6 and 12.9 percent, respectively.
Pre-culture morphological classifications and subsequent 
development of embryos in vitro is shown in table 2. None of the 
UFO, or the 2 Cell through 32 Cell embryos developed in culture.
While only 20.6 percent of the MOR classification developed in vitro, 
the combined blastocyst morphological classification had a greater 
percentage of embryos developing (76.7%) than any other morphological 
classification. Pregnancy rates of embryo transfers from morula 
(44%) have been shown to be significantly lower than that of blasto­
cysts (66%) (Wright, 1981). Table 3 presents the post-culture morpho­
logical classification of embryos and ova with their result in 
development. Higher percentages of the later morphological 
classifications of embryos resulted in development in vitro. A
18
TABLE 2. PRE-CULTURE MORPHOLOGICAL CLASSIFICATION 
OF EMBRYOS AND OVA AND DEVELOPMENT AFTER 
CULTURE
Pre-culture morphological 
classification (n)
No. of embryos 
developing in vitro % Developing
Unfertilized ova 38 0 0
Two-Cell 2 0 0
Four-Cell 2 0 0
Sixteen-Cell 1 0 0
Thirty-two-Cell 4 0 0
Morula 63 13 20.6
Advanced morulae 9 8 88.9
Early blastocysts 21 15 71.4
Blastocysts 1 0 0
Expanded blastocysts 21 18 85.7
Total 162 54 33.3
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TABLE 3. POST-CULTURE MORPHOLOGICAL CLASSIFICATION 
OF EMBRYOS AND OVA AND DEVELOPMENT AFTER 
CULTURE
Pre-culture morphological 
classification (n)
No. of embryos 
developing in vitro 7o Developing
Unfertilized ova 38 0 0
Two-Cell 2 0 0
Four-Cell 2 0 0
Sixteen-Cell 4 0 0
Thirty-two-Cell 4 0 0
Morula 55 4 7.3
Advanced morulae 2 0 0
Early blastocysts 10 4 40.0
Blastocysts 3 2 66.7
Expanded blastocysts 32 28 87.5
Hatching blastocysts 13 12 100.0
Total 162 54 33.3
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total of thirteen hatched blastocysts (HTB) were formed from 
developing blastocysts and resulted in a 100% in vitro development.
Morphological grading of embryos is considered to be one of 
the most important decisions made in the embryo transfer procedure. 
The ability to successfully predict embryo development by morpho­
logical grading only is acquired by diligent practice and profes­
sional training. Pre-culture morphological grading assessments of 
embryos and their subsequent development in culture is depicted in 
table 4. Embryos receiving pre-culture Grades of 1 had the greatest 
probability of developing (82.5%). Pre-culture Grade of 2 was 
almost as good with 61.3 percent developing; of Grade 3 embryos, 
only 6.9 percent resulted in positive in vitro development. None 
of the 24 Grade 4 embryos resulted in positive development. Although 
great subjectivity is known to exist in grading embryos morpholog­
ically, and large variability exists between embryo transplant 
laboratories, similar results have been reported by Wright (1981) 
and Shea (1981). Similar trends in post-culture grading assessments 
of embryos (table 5) were found as were discussed in pre-culture 
morphological grade assessments. Generally, the lower morphological 
grade the higher the percentage of embryos that result in positive 
in vitro development. Unlike the pre-culture assessments, there were 
three of 52 embryos (5.8%) that developed in vitro to a post-culture 
morphological grade of 4. A total of 54 embryos resulted in positive 
in vitro development for an overall culture development rate of 43.5 
percent.
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TABLE 4. PRE-CULTURE MORPHOLOGICAL GRADING ASSESSMENTS OF 
EMBRYOS AND THEIR SUBSEQUENT DEVELOPMENT 
IN CULTURE3
Pre-culture grades (n)
No. of embryos 
developing in culture % embryos developing
1 40 33 82.5
2 31 19 61.3
3 29 2 6.9
4 24 0 0
Total 124 54 43.6
aOnly fertilized ova included.
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TABLE 5. POST-CULTURE MORPHOLOGICAL GRADING ASSESSMENTS OF 
EMBRYOS AND DEVELOPMENT IN VITRO3
Post-culture grades
No. of embryos 
(n) developing in culture % developing
1 31 30 96.8
2 21 14 66.7
3 13 7 35.0
4 52 _3 5.8
Total 124 54 43.5
Only fertilized ova included.
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Table 6 demonstrates the use of pre-culture fluorometric 
assessments with FDA viability stain as first described by Rotman 
and Papermaster (1966). Only one UFO fluoresced at pre-culture 
evaluation out of a total of 38 (2.6%). The individual fluorometric 
score of this UFO was 2.5. FDA has been utilized to indicate via­
bility of unfertilized mouse ova (Jackowski, 1977) when collected 
near the time of ovulation, but considerable degeneration of bovine 
UFO was apparent when collected on day 7 of the estrous cycle. Since 
fluorometric scores of UFO were predominately 0, UFO were deleted 
from these tabular data. No development was observed of embryos given 
fluorometric scores of 0 or .5, while embryos with increasing fluoro­
metric scores of 1 through 4, showed correspondingly improved per­
centages of positive development in vitro. Embryos with the highest 
fluorescent score of 4 (n = 23) proved to have the highest percen­
tage of positive development in vitro (95.7%). Post-culture fluoro­
metric scores of embryos (table 7) gave a better indication of 
positive development in vitro. Only 9.3 percent of all embryos 
showing any fluorescence after 12 h of culture did not result in 
positive development (5/54). These results are in general agree­
ment with those of Nieman et al. (1981) who reported that only 16.3 
percent of embryos which showed positive fluorescence did not develop 
in vitro. Nieman et al. (1981) also reported that the use of FDA 
increased the accuracy of embryo evaluation in their laboratory by 
8 to 10 percent.
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TABLE 6. PRE-CULTURE FLUOROMETRIC ASSESSMENTS OF EMBRYOS 
AND THEIR DEVELOPMENT AFTER CULTURE3
Pre-culture fluorometric No. of embryos
scores (n) developing in culture % developing
0.0 14 0 0
1.5 6 0 0
1.0 15 1 6.7
1.5 6 1 16.7
2.0 18 7 38.9
2.5 18 9 50.0
3.0 21 12 57.1
3.5 3 2 66.7
4.0 23 22 95.7
Total 124 54 43.5
£
Only fertilized ova included.
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TABLE 7. POST-CULTURE FLUOROMETRIC ASSESSMENTS OF 
EMBRYOS AND DEVELOPMENT AFTER CULTURE3
Post-culture fluorometric No. of embryos
grades (n) developing Iji vitro % developing
0.0 70 6 8.6
0.5 18 14 77.8
1.0 11 10 90.9
1.5 — — —
2.0 2 1 50.0
2.5 3 3 100.0
3.0 6 6 100.0
3.5 10 10 100.0
4.0 4 4 100.0
Total 124 54 43.5
Only fertilized ova included.
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Simple correlations between viability indicators of embryos 
that resulted in positive development (table 8) indicated that a 
strong negative relationship existed between morphological grading 
assessments and fluorometric scores of pre-culture and post-culture 
evaluations. Strong positive relationships exist between pre-culture 
morphological grading assessments and post-cultural grading assess­
ments, as well as between pre-culture fluorometric scores and post­
culture scores. Although all possible relationships are statistically 
significant, the strongest relationship is found between pre-culture 
morphological grade and pre-culture fluorescence (r = -.71; P < .0001). 
Simple correlations between viability indicators of embryos and ova 
that resulted in negative development (table 9) support a somewhat 
lesser degree of relationship as compared with simple correlations 
of viability indicators of embryos that resulted in positive develop­
ment in vitro. A significant positive relationship was found between 
pre-culture morphologicasl grade and pre-culture fluorescence scores. 
This relationship was realized probably by assessments of morpho­
logical grade indicating high quality embryos but with poor fluo­
rescence scores. Therefore, this phenomenon probably accounted for an 
undetermined number of embryos that resulted in negative development 
which were either dead or dying at the time of pre-culture evaluation 
as assessed by the more biologically sensitive FDA test. These same 
embryos were previously assessed morphologically as being of a high 
quality.
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TABLE 8. SIMPLE CORRELATION COEFFICIENTS OF VIABILITY 
INDICATORS OF EMBRYOS THAT DEVELOPED 
IN VITRO3
PRE-GRADE1 PRE-FLUOR2 POST-GRADE3 POST-FLUOR4
PRE-GRADE — .60*** -.62***
PRE-FLUOR — -.43** .66***
POST-GRADE — -.60***
an = 54
"^PRE-GRADE = pre-culture morphological grade assessment.
2
PRE-FLUOR = pre-culture fluorometric score.
3
POST-GRADE = post-culture morphological grade assessment. 
^POST-FLUOR = post-culture fluorometric score.
**P < .01.
***P < .001.
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TABLE 9. SIMPLE CORRELATION COEFFICIENTS OF VIABILITY 
INDICATORS OF EMBRYOS AND OVA THAT DID NOT 
DEVELOP IN VITRO3
PRE-GRADE1 PRE-FLUOR2 POST-GRADE3 POST-FLUOR4
PRE-GRADE — . 29** .93*** -.003
PRE-FLUOR — -.49*** .32**
POST-GRADE — .02
an = 108
"^PRE-GRADE = pre-culture morphological grade assessment.
2
PRE-FLUOR = pre-culture fluorometric score.
3
POST-GRADE = post-culture morphological grade assessment.
4POST-FLUOR = post-culture fluorometric score.
**P < .01 
***P < .001
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Mean values for pre-culture and post-culture viability 
indicators of grade and fluorescence of all morphological classi­
fications of embryos and ova are shown in table 10. Mean pre- and 
post-culture grading assessment scores decreased, indicating 
increasing viability, as the morphological classification of embryos 
and ova developed into stages that are usually considered normal 
for non-surgical collection at day 7.0 post-estrus. Correspondingly, 
increasing fluorescence at both pre- and post-culture assessments 
indicated greater viability of embryos that are further developed 
and were characteristic of morphological classification from donors 
non-surgically collected at day 7.0-7.5 after estrus. The morpho­
logical classification of hatched blastocysts (HTB) was not repre­
sented in pre-culture assessments, since they developed from expanded 
blastocysts during in vitro culture. These HTB (n = 13) had the 
lowest overall mean grading assessment score (1.23) and the highest 
mean fluorescence score (2.88) of all embryos evaluated at the post­
culture evaluation.
In table 11 are the mean values for grade and fluorescence 
scores for embryos and ova by positive or negative in vitro develop­
ment during culture. Embryos of the thirty-two cell, sixteen-cell, 
four-cell and two-cell stages and unfertilized ova did not result in 
positive in vitro development. Morphological grade and fluorescence 
scores of these negative developing embryos were a constant indication 
of cellular degeneration and decreased viability. Morphological 
grades and fluorescence scores of MOR through HTB were lower and
TABLE 10. MEAN VALUES FOR PRE-CULTURE AND POST-CULTURE VIABILITY INDICATORS OF
MORPHOLOGICAL CLASSIFICATIONS OF EMBRYOS AND OVA
Morphological
classification
Pre-■culture assessments Post--culture assessments
(n ) Grade Fluorescence (n) Grade Fluorescence
UFO 38 .0 .06 38 .0 .0
2 Cell 2 4.0 .5 2 4.0 .0
4 Cell 2 4.0 .5 2 4.0 .0
16 Cell 1 4.0 .5 1 4.0 .0
32 Cell 4 3.75 1.25 3 4.0 .0
MOR 63 2.84 1.69 55 3.67 .09
AMOR 9 1.33 2.55 2 2.00 1.00
ERB 21 1.69 2.52 10 2.45 .75
BLA 1 1.00 3.00 3 2.67 .16
EXB 21 1.69 2.52 33 1.63 1.45
HTB — — — 13 1.23 2.88
Morphological classification: UFO = unfertilized, 2 Cell = two cell, 4 Cell = four cell,
16 Cell = sixteen cell, 32 Cell = thirty-two cell, MOR = morula, AMOR = advanced morula, ERB = 
early blastocyst, BLA = blastocyst, EXB = expanded blastocyst and HTB = hatched blastocyst.
TABLE 11. MEAN VALUES FOR VIABILITY. INDICATORS FOR EMBRYOS AND OVA THAT RESULTED 
IN POSITIVE AND NEGATIVE IN VITRO DEVELOPMENT BY ALL MORPHOLOGICAL
CLASSIFICATIONS
Morphological
classification
Positive in-yitm development Negative in.-vitro development
( n ) Grade Fluorescence ( n ) Grade Fluorescence
UFO 0 — — 76 .00 .03
2 Cell 0 — — 4 4.00 .25
4 Cell 0 — — 4 4.00 .25
16 Cell 0 — — 2 4.00 .25
32 Cell 0 — — 7 3.86 .71
MOR 17 2.29 2.18 101 3.86 .74
AMOR 10 1.40 2.40 1 2.00 1.00
ERB 19 1.70 2.55 12 2.29 1.00
BLA 2 2.00 .25 2 2.50 1.50
EXB 47 1.33 2.54 7 2.00 1.42
HTB 13 1.23 2.88 0 — —
Morphological classification: UFO = unfertilized, 2 Cell = two-cell, 4 Cell = four-cell,
16 Cell = sixteen-cell, 32 Cell = thirty-two-cell, MOR = morula, AMOR = advanced morula, ERB = 
early blastocyst, BLA = blastocyst, EXB = expanded blastocyst and HTB = hatched blastocyst.
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higher, respectively, for embryos showing positive development as 
compared with embryos showing negative development in culture. Since 
matched blastocysts resulted in 100 percent positive development in 
vitro no values appear in the negative in-vitro development segment 
of table 11.
Analysis of variance (table 12) indicated significant dif­
ferences occurred for morphological grade assessments between 
positive and negative developing MOR and EXB. There was also sig­
nificant variation of morphological grade assessments between pre- 
and post-culture evaluation times of MOR and EXB, while the AMOR 
classification approached significance (P < .10).
A significant interaction between result and culture time 
(P < .05) for morula morphologically classified embryos indicated 
that MOR resulted in positive or negative in vitro development dif­
ferently due to culture time. This interaction can be explained 
by the fact that some embryos responded readily to in vitro culture 
and exhibited post-culture morphological grading assessments to 
indicate high quality (low grading scores) whereas their pre-culture 
grading scores indicated low quality (high grading scores). Morulae 
also had the widest ranges of morphological grading assessments of 
all the different embryo classifications. Wright (unpublished data) 
has suggested that the uterine environment of superovulated donors
becomes hostile due to a distinct imbalance in the hormonal patterns. 
This hostile environment may retard the embryo for a short time
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TABLE 12. ANALYSIS OF VARIANCE OF FDA-TREATED EMBRYOS BY 
MORPHOLOGICAL CLASSIFICATION OF GRADE 
ASSESSMENTS
Source
Mean squares for morphological 
Morphology classification3
grade
MOR AMOR ERB BLA EXB
Result (R) 4.92** .50 1.13 2.67 2.49*
Culture Time (C) 13.00** .90 + 2.50 4.50 4.29**
R x C 2.57* — .08 — .59
Error .44 .19 .57 2.00 .462
(114)c (8) (27) (1) (49)
aMorphology classification : MOR = morula, AMOR = advanced
morula, ERB = early blastocyst, BLA = blastocyst and EXB =
expanded blastocyst.
^Morphology classification of thirty-two cell or less and 
hatched blastocyst were not represented in either result and/or 
culture time.
cError (df)
+P < .10
*P < .05
**P < .01
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without causing death and may account for its subsequent favorable 
response in culture.
Analysis of variance (table 13) indicated significant vari­
ation of fluorescent assessments between positive and negative 
developing morula, early blastocysts and expanded blastocysts, while 
the advance morula morphological classification approached signifi­
cance (P < .10). A significant variation of fluorescent assessments 
was also found between pre-culture and post-culture evaluations for 
thirty-two cell, morula and expanded blastocysts, while advanced 
morula and blastocysts approached significance (P < .10).
Least squares means are shown in tabular form (table 14) for 
morphological grade assessments of embryos and ova by culture time.
A significant increase in morphological grading scores indicated 
poorer embryo viability of post-culture assessments of both MOR 
and EXB classifications. Post-culture morphological grades tended 
to be lower in embryos of normal developmental classifications than 
pre-culture grades, but these differences were not significant.
Least squares means of morphological grade assessments for the 
small number of embryos, representing abnormal morphological clas­
sifications (thirty-two cell, sixteen cell, four cell, two cell) 
were essentially the same for both the pre-culture or post-culture 
evaluation times.
Fluorescent scores represented by least squares means are 
shown in table 15 for all morphological classifications of embryos 
and ova by pre- and post-culture evaluation time. A significantly
TABLE 13. ANALYSIS OF VARIANCE OF FDA TREATED EMBRYOS BY 
MORPHOLOGICAL CLASSIFICATION OF FLUORESCENT 
ASSESSMENTS
Mean squares for fluorescence 
Morphology classification
Source UFO 2 Cell 4 Cell 32 Cell MOR AMOR ERB BLA EXB
Result (R) — — — — 8.64** 2.72t 7.73** .04 7.75*
Culture Time (C)
00o .25 .25 2.68** 32.09** 4.90 12.28 4.50t 41.60**
R X C — — — — 1.07 — .04 — .915
Error .08 .25 .25 .05 .53 .68 1.0 .125 1.153
(74) c (2) (2) (5) (114) (8) (27) (1) (49)
Morphology classification: UFO = unfertilized, 2 Cell = two-cell, 4 Cell = four-cell, 32 Cell =
thirty-two cell, MOR = morula, ERB = early blastocyst, BLA = blastocyst and EXB = expanded blastocyst.
Sixteen cell and hatched blastocyst morphology not represented in result or culture time. 
cError (df) 
tP < .10 
*P < .05 
**P < .01
LO
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TABLE 14. LEAST SQUARES MEANS AND STANDARD ERRORS OF 
MORPHOLOGICAL GRADE ASSESSMENTS AT 
PRE-CULTURE AND POST-CULTURE TIMES
Morphological a ^ Culture time
classification ’ Pre-culture Post-culture
UFO .00 + .000 .00 + .000
2 Cell 4.00 + .000 4.00 + .000
4 Cell 4.00 + .000 4.00 + .000
16 Cell 4.00 + .000 4.00 + .000
32 Cell 3.75 + .194 4.00 + .224
MOR 2.50 +
aoo
3.59 + .173'
AMOR 1.63 + .229 2.38 + .383
ERB 1.78 + .182 2.39 + .243
BLA 1.00 + 1.53 2.67 + .882
EXB 1.17 + .211° 2.01 + .182'
Morphological classification: UFO = unfertilized, 2 cell =
two cell, 4 cell = four cell, 16 cell = sixteen cell, 32 cell = thirty- 
two cell, MOR = morula, AMOR = advanced morula, BLA = blastocyst and 
EXB = expanded blastocyst.
^Hatched blastocyst was not represented in pre-culture assess­
ment and was not included in these data.
c d’ Values in the same row with different superscripts differ 
(P < .01).
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TABLE 15. LEAST SQUARES MEANS AND STANDARD ERRORS OF 
FLUORESCENT ASSESSMENTS AT PRE-CULTURE 
AND POST-CULTURE TIMES
Morphological Culture time
classification3 ’^ Pre-culture Post-culture
UFO .06 + .047 .00 + .047
2 Cell .50 + .350 .00 + .350
4 Cell .50 + .350 .00 + .350
16 Cell .50 + .350 .00 + .350
32 Cell 1.25 + .110c .00 + .130'
MOR 2.05 + .113° .34 + .188'
AMOR 1.88 + .439 .13 + .732
BLA 3.00 + . 288c .16 + .167'
EXB 3.38 + . 280° 1.02 + .250'
Morphological classification: UFO = unfertilized, 2 Cell =
two cell, 4 Cell = four cell, 16 Cell = sixteen cell, 32 Cell = thirty- 
two cell, MOR = morula, AMOR = advanced morula, BLA = blastocyst and 
EXB = expanded blastocyst.
^Hatched blastocyst was not represented in pre-culture assessment 
and was not included in these data.
c’Malues in the same row with different superscripts differ 
(P < .01).
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higher fluorescence score was found at pre-culture evaluations as 
compared to post-culture evaluations of thirty-two cell, morula, 
blastocyst and expanded blastocyst embryos. Mohr and Trounson
(1980) indicated that loss of intracellular fluorescein was affected 
by culture time of the stained embryos and the temperature at which 
the embryos were stored.
Table 16 contains the least square means of morphological 
grade assessments of embryos that resulted in positive or negative 
development during in vitro culture. Morphological classifications 
of morula and expanded blastocysts that resulted in positive in vitro 
development had significantly lower morphological grading scores, 
indicating greater embryo viability, than did embryos that resulted 
in negative in vitro development. In general, morphological grading 
scores were lower for embryos that resulted in positive in vitro 
development compared to embryos that did not show any positive 
development. These observations are in general agreement with data 
from Schneider (1980) where embryos of morphological grades indi­
cating good viability resulted in higher pregnancy rates compared with 
embryos given morphological grades indicative of poorer quality.
Fluorescent assessments of embryos that resulted in posi­
tive in vitro development were higher than for embryos that resulted 
in negative development (table 17). Significantly increased fluo­
rescence scores were found in positive developing embryos of the 
morphological classifications of morula, advanced morula, early 
blastocyst and expanded blastocyst. Schilling et al. (1979) reported
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TABLE 16. LEAST SQUARES MEANS AND STANDARD ERRORS OF MORPHOLOGICAL 
GRADE ASSESSMENTS OF EMBRYOS THAT RESULTED IN POSITIVE 
OR NEGATIVE DEVELOPMENT IN CULTURE
Morphological  Result in culture________
classification3 ’^  Positive Negative
MOR 2.71 + .190c 3.38 + . 066d
AMOR 1.63 + .171 2.38 + .466
ERB 1.89 + .190 2.29 + .214
BLA 2.00 + 1.275 2.50 + 1.275
EXB 1.26 + .103c 1.96 + . 258d
aMorphological classification: MOR = morula, AMOR = advanced 
morula, ERB = early blastocyst, BLA = blastocyst and EXB = expanded 
blastocyst.
Morphological classifications of thirty-two cell embryos or 
less and unfertilized ova did not result in development and are not 
represented in these data.
c d’ Values in the same row with different superscripts differ 
(P < .01).
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TABLE 17. LEAST SQUARES MEANS AND STANDARD ERRORS 
OF FLUORESCENT ASSESSMENTS OF EMBRYOS 
THAT RESULTED IN POSITIVE OR NEGATIVE 
DEVELOPMENT IN CULTURE
Morphological Result in culture
classificationa,k Positive Negative
MOR 1.64 + . 208c .750 + . 072d
AMOR 1.88 + . 330c .125 + .892d
ERB 2.12 + .282° 1.00 + . 290d
BLA 1.75 + .354 1.50 + .250
EXB 2.79 + .162° 1.65 + .410d
aMorphological classification: MOR = morula, AMOR = advanced
morula, ERB = early blastocyst, BLA = blastocyst and EXB = expanded 
blastocyst.
^Morphological classifications of thirty-two cell embryos or 
less and unfertilized ova did not result in development and are not 
represented in these data.
c d’ Values in the same row with different superscripts differ 
(P < .01).
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similar observations when utilizing the FDA viability test on early 
bovine embryos. In this latter study a 24 h incubation period was 
utilized to evaluate embryo mitotic activity and results indicated 
a higher percentage of mitotic activity was associated with the 
greatest amount of fluorescence at the preculture evaluation time. 
Several reports also reflect this general agreement associated with 
higher fluorescent scores and positive development in culture (Renard 
et al., 1982; Jackowaski, 1977; Nieman et al., 1981).
REVIEW OF LITERATURE 
Olafson et al. (1946) described an apparently new disease of 
dairy cattle in the state of New York. The disease was found to be 
contagious, and could be transmitted to non-affected cattle by 
parenteral injection of defibrinated blood, splenic tissue and other 
organs. Pritchard et al. (1954) later described a similar disease 
in dairy and beef cattle in Indiana. For a short time the researchers 
thought the two diseases were entirely different and were described 
as virus diarrhea in the state of New York and virus diarrhea in the 
state of Indiana. Gillespie and Baker (1959) compared the Indiana 
and New York strains of the virus and found no immunological or 
clinical differences between them. At this time it was proposed 
that only one strain of virus diarrhea existed in the United States.
Ramsey and Chivers (1953), while working with cytopathogenic 
strains of the virus known to cause mucosal disease,found similar­
ities to the cytopathogenic strains of virus diarrhea. In 1971, 
the American Veterinary Medical Association termed the disease 
collectively as bovine virus diarrhea-mucosal disease.
Disease Prevalance
Bovine virus diarrhea (BVD) has been diagnosed in many 
countries of the world including the United States, Australia,
Canada, Germany, England, Scotland, Sweden, Japan, and Argentina.
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The only reported clinical cases of this worldwide disease involve 
cattle of all ages and is most frequently found during the late winter 
and spring (Gillespie and Timoney, 1981).
Kahrs et al. (1964) found that 53 percent of all cows in a 
New York state study had antibodies for BVD, and a study conducted 
in Florida by Knaizeff (1963) showed that 65 percent of beef cattle 
and 61 percent of dairy cattle had BVD antibodies. Seger (1968) 
reported that 80 percent of samples from Louisiana cattle were 
serologically positive for BVD. Other surveys of states revealed 
similar results: 59 percent in Illinois, 69 percent in Iowa and
73 percent in Nebraska (Newberne et al., 1961).
Kahrs et al. (1964) demonstrated positive neutralizing 
antibodies for BVD in sera from White-tailed deer, while Richards 
(1956) described a disease of White-tailed deer and Mule deer from 
North Dakota in which the lesions were similar to those found in 
cattle with BVD. Pronghorn sheep have also been found to have BVD 
antibodies (Barrett and Chambers, 1975). BVD antibodies have also 
been demonstrated in the sera of sheep and goats. It has been 
suggested that BVD virus can elicit an inapparent infection in 
both species (Taylor et al., 1977a,b). Domestic swine in the USA 
can experience natural infection by the BVD virus. However, no 
apparent signs of illness are evident following BVD infection in 
this species (Stewart et al., 1971; Carbrey et al., 1976).
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Characteristics of BVD Virus
Bovine viral diarrhea virus belongs to the family 
Togaviridae which is presently divided into four genera. Alphavirus 
includes group A arboviruses and Flavivirus includes all group B 
arboviruses. The other two genera consist of previously unclassified 
viruses: Pestivirus and Rubivirus. The Pestivirus genus includes
viruses closely related to hog cholera, and Rubivirus includes 
rubella virus (Roberts and Carter, 1976). Since the principal 
nucleic acid in the BVD virus is ribonucleic acid it was termed an 
RNA virus. The RNA is single-stranded, present in one molecule and 
has a molecular weight of 4 x 10^ daltons. The BVD virus has a 
cubical, capsidal symmetry with a configuration of 32 capsomers.
The virion has a characteristic envelope without an associated 
transcriptase (Roberts and Carter, 1976). The sedimentation coef­
ficient of the virus particle is 80 to 90-S and its buoyant density 
is 1.14 to 1.15 g per ml in a sucrose-density gradient (Fernelius, 
1968). Inactivation of the live virus can be accomplished with 
chloroform and ether (Gillespie et al., 1963). Chemotoxic sub­
stances, such as 5-iodo-deoxyuridine and 5-bromo-deoxyuridine do 
not inhibit growth of the Oregon strain of BVD (Hermodsson and Dinter,
1962). The BVD virus is readily maintained in a lyophilized or frozen 
state at -60 to -70 C for many years. However, Gratzek (1961) 
observed a 10-fold loss of virus viability in 24 hours at 26 C and 
37 C. In contrast, Coggins (unpublished data) found no apparent
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loss of viability of the Oregon strain of BVD virus following storage 
at 25 C for 24 hours. Electron micrographs of Oregon strain of BVD 
virus, processed in chromium, demonstrated this virus to be rela­
tively spherical and ranging in size from 35 to 55 nm (Pritchard,
1963). Hermodsson and Dinter (1962) also found the virus particles 
to be spherical and to measure approximately 40 nm. In contrast, 
three major size classes of BVD virus particles were observed by 
Ritchie and Fernelius (1969) using phosphotungstic acid and electron 
microscopy. Maess and Reczko (1970) using ultracentrifugation, den- 
sity-gradient centrifugation and rate zonal centrifugation in sucrose, 
along with electron microscopy showed that the virion consists of 
an envelope without projections and a nucleocapsid with cubical 
symmetry. They found the entire particle to be approximately 57 ±
7 nm with a core diameter of 24 ± 4 nm. Millipore filtration studies 
by Doyle (1933) and Fernelius (1968) indicated that the size of 
viral particles were less than 50 nm which agreed with results 
obtained using electron microscopy. It is usually considered that 
virus of the family Togaviridae range in size from 40 to 60 nm 
(Roberts and Carter, 1976).
Virus Replication
Replication of most ribonucleic acid (RNA) viruses occurs 
primarily in the cytoplasm of cells and is independent of nuclear 
activity. Exceptions to this general rule include orthomyxovirus 
which require host deoxyribonucleic acid (DNA) transcription,
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paramyxoviruses which have a non-obligatory nuclear phase of 
replication and retroviruses which replicate through a DNA inter­
mediate (Goodheart, 1969).
The three steps in replication of RNA viruses consist of 
(1) electrostatic interaction between the virus and specific cell 
receptors, (2) virus entering the cell by viropexis (pinocytosis) 
or by fusing with the cell membrane and (3) release of the viral 
nucleic acid in the cytoplasm (Goodheart, 1969).
In general, replication of RNA is semi-conservative and 
proceeds through a replicative intermediate (RI). The RI consists 
of the parental strand of viral RNA which serves as a template for 
the transcription of several RNA strands. These RNA strands 
eventually "peel off" and serve as templates for the synthesis 
of viral RNA (Goodheart, 1969; Roberts and Carter, 1979). Viral 
RNA molecules result in mature progeny virions by encapsulation. 
Subsequently, there is lysis of the host cell and release of viral 
particles. Olson et al. (1968) provided knowledge on the ability 
of viruses to replicate within specific cell lines. These workers 
observed depression of lymphocyte reactivity after in vitro infec­
tion with rubella virus. Inhibition of protein synthesis was 
observed and the possible mode of action was through the virus's 
ability to synthesize new ribonucleic acid and block the ribosomal 
sites on the lymphocyte. Muscoplat et al. (1973) demonstrated that 
the bovine viral diarrhea virus could inhibit mitosis induced by
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phytohemagglutinin of normal bovine lymphocytes cultured in vitro 
with bovine fetal serum.
Pathogenicity of BVD
The first classification of BVD by Olafson et al. (1946) in 
New York State was described initially as suspected feed poisoning 
because of the gastro-enteritis and severe signs of diarrhea observed 
in the disease. Laboratory analysis of the feed was negative for 
tests of toxicosis and led to a more precise documentation of the 
signs of the new disease. The involved animals were severely dehy­
drated and epithelial erosion were found on the dental pad, palate 
and lateral tongue surface, around the incisors and on the inside 
of the cheeks. Erosions were occasionally seen on the muzzle and at 
the entrance of the nostrils. Ulceration of the pharynx and larynx 
and diffuse necrosis of the mucuos membranes of these regions 
occurred in animals which later died (Olafson et al., 1946).
Present descriptions of clinical disease differs from 
previous reports from the states of New York or Indiana. In the 
early reports, morbidity rates were high and cattle of all ages 
were affected. Earlier researchers suggested that most cattle 
infected by BVD survived, but today the disease occurs sporadically 
and frequently results in death of the animal (Kahrs, 1980).
The disease caused by the BVD virus generally affects 
cattle between the ages of 6 to 24 months old but mature cattle 
can also be affected. In herds where acute cases were found,
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herdmates usually appear normal, but careful examination indicated 
that subclinical disease was also present. The typical case is 
characterized by an elevated temperature, salivation, gingivitis 
and erosions of the mucous membranes of the lips, gums and palate. 
Diarrhea is not always present in the acute form of the disease, but 
when present it is usually the cause of severe dehydration that may 
lead to death. Rapid respiratory rates and leukopenia are usually 
observed in cattle experiencing BVD. Acute laminitis with partial 
alopecia and corneal opacity are occasionally observed (Kahrs, 1980).
The chronic form of the disease is most commonly known as 
the mucosal disease syndrome. Cattle with the chronic form of the 
disease may appear as though they are recovering from an acute form, 
but it can also occur without prior evidence of the disease in the 
herd. Infected cattle lose weight and become unthrifty. Inter­
mittent bouts of diarrhea are observed in affected animals. Other 
signs of chronic BVD infection include dry and scruffy skin, lame­
ness, cracking or necrosis of skin in the interdigital spaces, and 
erosions and necrosis around the coronary band. Cattle experiencing 
chronic BVD infection may have any of the lesions of the acute form. 
These acute lesions may heal rapidly but can reappear throughout 
the course of the disease, which can last for several months. The 
BVD virus can be isolated from samples of blood serum, ocular and 
nasal secretions (Kahrs, 1980) and uterocervical secretions (Archbald, 
1974) of chronically infected cattle. These chronically infected 
cattle fail to develop sufficient circulating antibodies and appear
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to be incapable of mounting an immunological response to the BVD 
virus. In extreme cases of chronic BVD infection the decline in 
physical status results in death (Kahrs, 1980; Gillespie and Timoney, 
1981), although most of these animals are culled from the herd.
Mild clinical BVD infection is characterized by fever and 
leukopenia, both of which may affect cattle without detection. The 
disease in this form may be associated with increased respiratory 
rate and a few scattered erosins of the oral mucosa or a few 
reddened buccal papillae. The mild signs of the disease are 
usually not observed and therefore infection by the BVD virus may 
not be apparent. However a careful examination of the oral cavity 
of animals with mild diarrhea and some sign of respiratory distress, 
especially if these animals reside in herds where acute and chronic 
BVD has been detected, will reveal reddened and blunted buccal 
papillae. Necropsy and further laboratory tests will usually pro­
vide evidence of BVD infection. It is this form of BVD that may 
cause the greatest losses due to failure in reproduction (Kahrs, 
1980).
Postvaccinal Reactions to BVD Vaccines
Bovine viral diarrhea vaccines have been commercially 
available since 1964. These vaccines utilize either the Oregon 
C24 strain or the National Animal Disease Laboratory (NADL) strain 
of the BVD virus. Production of vaccines for use in interstate 
commerce is regulated by the Veterinary Biological Service of the
Animal and Plant Health Inspection Services of the U.S. Department of 
Agriculture (USDA, 1972). To obtain the license for marketing and 
distribution of a BVD vaccine the producer must demonstrate that the 
vaccine is free of adventitious viral, mycoplasmal, bacterial and 
mycotic agents (Lambert, 1973) and must pass a series of safety and 
potency tests.
Careful monitoring of potency and safety of the BVD vaccines 
is under the jurisdiction of the USDA at its specific agencies. 
However, these specially controlled tests may be in vain if handling 
of the product in the field is inappropriate. Proper care and 
storage of the vaccine before and during use are extremely important. 
Direct sunlight and temperatures above 4C for prolonged periods can 
inactivate the vaccine. Therefore, proper refrigeration during field 
conditions is essential to ensure optimal potency (Lambert, 1973).
All forms of the BVD infection can occasionally occur 
following vaccination with modified live virus (MLV) vaccines. 
Evidence of BVD infection usually occur 7-20 days postvaccination 
in a very few cattle (Lambert and Fuller, 1970). Clark (1968) 
reported that 178 of 93,621 (0.19%) developed the clinical mucosal 
disease syndrome about 13 days postvaccination. The incidence of 
postvaccinal reactions to BVD may be higher in individual herds due 
to the health status of the cattle vaccinated. The vaccination of 
pregnant dams is not recommended since abortion and fetal damage 
are common sequelae (Kendrick, 1971). It is generally recommended
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that vaccination of open heifers and cows be done at least 30 days 
prior to breeding or rebreeding (Lambert, 1973).
In order to prevent the occurrence of the reactions after
BVD vaccination in cattle, research was initiated to produce a safer
potent BVD vaccine. Fernelius et al. (1972) developed two methods
of inactivation of the BVD virus for subsequent vaccine production.
The Beta-propiolactone treatment inactivated the live virus while
retaining its high antigenic and immunogenic properties. The
chloroform-treated vaccine developed by Fernelius et al. (1972)
exhibited good antigenic properties but its apparent immunogenic
properties were not as superior as the one prepared by inactivation
of the virus by Beta-propiolactone treatment. Further research
proved that the vaccine produced by inactivation of the BVD virus
with Beta propiolactone resulted in a serviceable immunity level
and a second inoculation 2 to 3 weeks later was beneficial in
increasing levels of circulating antibodies against the BVD
virus. Recently, Fort Dodge Laboratories, Fort Dodge, Iowa has
introduced the first killed vaccine for BVD. Triangle-1,'*' the new
inactivated BVD vaccine, will eliminate risks from post-vaccine
reactions which occur following use of live virus vaccines. Tri- 
R
angle-1 can be administered to pregnant cows, and eliminates the 
necessity to isolate cattle after vaccination. The recommended
1 R
Triangle-1 , Fort Dodge Laboratories, Fort Dodge, Iowa.
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vaccination program involves the use of Triangle-1 administered 
in a single dose to animals previously vaccinated with one or another 
MLV vaccine for BVD, followed by a booster dose once a year. For 
cattle never previously vaccinated for BVD, a two-dose series is 
recommended, followed by an annual vaccination.
Diagnosis of BVD
The diagnosis of BVD is generally based on the demonstration 
of signs and lesions characteristic of BVD. The diagnosis can be 
made on either the live animal or at necropsy.
Kahrs (1980) reported that the typical BVD infected carcass 
is thin, dehydrated and usually has a scruffy hair coat soiled with 
feces. The infected animal may have erosions or ulcerations of the 
mucous membranes of the oral cavity, esophagus, rumen and abomasum.
A characteristic finding is lymphoid depletion and hemorrhage or 
necrosis of Peyer's patches. Fatal cases of BVD may have necrotic 
areas around the skin of the lower limbs, especially in the areas of 
the coronary band.
Gillespie and Timoney (1981) emphasize that BVD can easily 
be confused clinically with Malignant Catarrhal fever or Rinderpest. 
They also noted that some bovine respiratory infections can be 
confused with BVD.
Everman and Faris (1981) reported on current cases of BVD 
infection from the northwestern section of the United States. From
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the total of 74 cases, 60 cases were associated with classical 
clinical signs of BVD infection. There were 34 of 60 cases (57%) 
that were observed with diarrhea, and 31 of 60 cases (52%) which 
had respiratory tract involvement. A small percentage of cases had 
oral lesions (11%), ocular manifestations (10%) and abortion (5%). 
Other reported clinical signs included enteritis without diarrhea, 
blood in feces and epidermatitis. Also reported were 11 cases of 
mixed viral infection with BVD virus. The dual infections included 
bovine enterovirus (respiratory distress), parainfluenza type 3 virus 
and bovine herepesvirus. Similarly, Greig (1981) described a disease 
outbreak in calves caused by a mixed infection with infectious bovine 
rhinotracheitis (IBR) virus and BVD virus. This severe outbreak of 
disease had presented the classical signs of IBR infection with 
lameness and marked alimentary tract involvement.
Since the clinical signs of BVD may not be apparent, diag­
nosis should be confirmed with several laboratory tests. At 
necropsy, viral isolation tests can confirm BVD virus infection 
from tissue samples of the spleen, lymph nodes or bone marrow. In 
the live animal, the virus can be isolated from blood, nasal or ocu­
lar discharges (Kahrs, 1980). Virus isolation techniques have been 
outlined by Rovozzo and Burke (1973) which include basic tissue cul­
ture techniques to determine cytopathogenic effect (CPE) in tissue 
cultures. Soto-Belloso et al. (1976) developed a cell culture line
of bovine fetal endometrial cells and demonstrated its use in 
determining cytopathogenic effects (CPE) of BVD virus. After 
three subpasses are made in cell culture without any cytopathogenic 
changes, alternate tests are employed which can identify non- 
cytopathogenic strains. Some laboratories rely upon fluorescent 
antibody tests (FAT) to determine the presence of BVD virus in 
tissues. Some problems exist when differentiating between Hog 
Cholera Virus (HCV) and BVD since the fluorescent-antibody conjugate 
detects both antigens. Also, the preparation of reagents frequently 
makes FAT an expensive diagnostic tool (Rovozzo and Burke, 1973).
Serological diagnosis is usually based on a serum neutra­
lization test performed in cell cultures. Rovozzo and Burke (1973) 
described the serum-neutralization test as bringing the serum and 
virus under specific conditions where inoculation into a suscep­
tible host (animal, egg, tissue culture) could be illustrative of 
the presence of antibodies. If antibodies for the virus in question 
were absent, disease, lesions or death might result to the host, or 
when antibodies were present, no such reactions were noted. Jensen 
(1981) demonstrated the use of a serological test that had the 
ability to differentiate between HCV and BVD. He experimented with 
three different methods for detection of antibodies from porcine 
serum collected from swine during a low-virulent outbreak of hog 
cholera in West Germany, as well as from a group of swine experi­
mentally inoculated with hog cholera virus and bovine viral diarrhea
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virus. He found that serum neutralization tests using the peroxidase- 
linked antibody could distinguish antibodies between HCV and BVD 
with a high degree of reliability. The use of serological diagnosis 
of BVD as described by Kahrs (1980) can be more beneficial if paired 
serum samples are taken, since there is a high prevailance of anti­
bodies to the BVD virus from previous infection or vaccination of 
most cattle populations. Paired sera can be used to determine 
seroconversion near the time of clinical disease.
The plaque technique as described by Singh (1969) and Rovozzo 
and Burke (1973) can also be used in assaying BVD virus in vitro.
The plaque technique is based on the formation of plaques or foci 
in or on various indicator systems. Two methods exist for counting 
infective particles: end point (all or none response) and scoring
for growth or actual counting of foci. The plaque technique is 
considered to be a highly quantitative technique and has been used 
for routine neutralization studies. Using the plaque technique 
distinct 3.5 mm plaques are identified 3 days following inocu­
lation, as compared with 7 to 10 days which are required for final 
reading of conventional CPE where liquid medium is used. An 
additional use of the plaque assay, as demonstrated by Roth et al.
(1981), was to purify the BVD isolate for later experimental studies.
Hopkinson (1979) developed a fast, simple and inexpensive 
test for determining BVD serum antibodies using immunodiffusion 
techniques. This assay method had a high correlation to the
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standard virus neutralization test. The latter is more expensive 
and requires more time in obtaining final results. However, the 
sensitivity of the immunodiffusion test is somewhat less than that 
of the virus-neutralization assay.
Muscoplat (1973) has demonstrated that in vitro lymphocyte 
response can be utilized as a diagnostic test for BVD infection.
An interesting research note observed in his work was that the BVD 
virus may alter the rate of deoxyribonucleic acid (DNA) synthesis 
by the lymphocytes. This important finding provided evidence to 
support the theory that the immunosuppression observed in fatal 
cases of BVD infection is possibly due to lymphocyte degradation.
Rapid diagnosis of virus diseases can be obtained by use 
of the electron microscope (EM). Gibbs et al. (1980) discussed the 
flexibility and speed by which viral isolates can be identified 
from clinical material on tissue culture with the electron micro­
scope. EM diagnosis of viruses can be based on the classification 
of different families of viruses with sometimes different genera 
whose characteristically different morphology allows simple identi­
fication. Specific techniques using EM for viral indentification 
include negative staining with a heavy metal stain such as phos- 
photungstic acid, immunoelectron microscopy in which a viral antigen 
is reacted with antibody, and finally thin sectioning. Disadvan­
tages of the use of the electron microscope in diagnosis of viral 
diseases were that high concentration of the virus is needed for
57
quantitative analysis and other tests for viral isolation must be 
used to verify the presumptive nature of the test.
Transmission of BVD
Bovine virus diarrhea is considered a viremic disease and 
secretions from acutely infected cattle contain virus. Fecal 
material, blood and splenic tissue are known vehicles for the 
transmission of the disease (Gillespie and Timoney, 1981). Roberts 
and Carter (1976) reported that the mode of transmission is by 
contact and fomites, and the avenue of infection is believed inges­
tion. Gillespie and Timoney (1981) suggest that sheep and goats 
may play a role in transmission of the virus to cattle. BVD can 
also occur as a natural infection in swine. Therefore, transmission 
can theoretically occur with susceptible animals. Wildlife, such 
as deer, have been shown to possess BVD neutralizing antibodies.
This wildlife covers large areas of land and may be one reason for 
the large population of cattle that have BVD antibodies (Richards, 
et al., 1956; Carlson, et al., 1957; and Kahrs, et al., 1964).
Experimental transmission of BVD is usually accomplished by 
oral drenching, intranasal or parenteral injection. However, sero­
negative cows inoculated in the uterus experienced seroconversion 
(Lambert, 1969; Archbald, 1973; and Timoney, 1981).
Venereal transmission of the BVD virus has not been reported, 
although the virus has been isolated from the urine of cattle pre­
viously infected with the virus (McKercher, 1969). Mills and
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Luginbuhl (1968), also reported isolation of BVD virus in urine 
and renal tissue of experimentally-infected calves 2 weeks after 
inoculation. These workers have noted the possibility of the 
shedding of the virus during copulation, thus suggesting venereal 
transmission. Whitmore et al. (1978) have reported isolation of BVD 
virus from experimentally-inoculated bulls. From a total of 98 
semen samples from nine bulls, four were found to harbor BVD virus.
The reproductive tracts from six of nine bulls were recovered and 
BVD virus was isolated from a testicle of one bull. In a more recent 
study, Shultz et al. (1982) reported data from viral screening of 
40,000 ejaculates from bulls housed in an artificial insemination 
(Al) cooperative. The only virus that was found was BVD virus.
These studies suggest that the bull can shed BVD virus in semen. 
Therefore, the bull theoretically, although unlikely, could transmit 
the disease to the female during copulation or Al.
Relationship of BVD to Abortion in Cattle
The initial report of bovine viral diarrhea by Olafson 
et al. (1946) stated that 20 abortions occurred 10 days to 3 
months after the outbreak of clinical signs of the disease.
This large variation in time from maternal infection to abortion 
can lead to problems in accurate diagnosis of the disease. Also,
BVD induced-abortion can occur in herds where BVD has never previously 
been diagnosed. Kendrick (1971) indicated that abortion occurred
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at a higher frequency when pregnant cows are infected early in 
gestation, but abortion has been observed following infection at all 
stages of fetal development (Kahrs et al., 1970a).
Clinical and epizootiologic observations of a dairy herd 
in New York State showed that of 29 pregnant cows, 10 pregnancies 
ended abnormally between 101 and 271 days of gestation. Necropsy of 
one fetus revealed abnormalities in the cerebellar folia of the 
brain. Serum antibody tests of pregnant cattle which do not abort 
indicate positive antibody titers protect cattle from subsequent 
reinfection and abortion. Susceptible cattle, whose antibody titers 
remain negative during a time of infection, usually become acutely 
infected and abort if pregnant. The high prevalance of BVD anti­
bodies in cattle populations accounts for the low occurrence of 
BVD-induced abortion with abortion storms due to BVD possible only 
under rare circumstances (Kahrs and Ward, 1967).
The mechanism by which the BVD virus causes fetal death and 
abortion are not clearly understood. The BVD virus has been shown 
to inhibit mitosis in lymphocytes stimulated by addition of 
phytohemagglutinin (Muscoplat, 1973). Olson (1968) demonstrated 
that Rubella virus can also inhibit lymphocyte mitotic activity by 
interference in blast transformation. The Rubella virus is a RNA 
virus of the Togavirus family and can cause spontaneous abortion, 
stillbirth and cogenital abnormalities in humans.
In the study by von Benten (1980), Hog Cholera Virus (HCV), 
which is another member of the Togavirus family, was experimentally
inoculated into pregnant sows to demonstrate the ability of the 
virus to cross the placenta membrane. Fetal mortality was highest 
at early gestational inoculation dates, and fetuses were found to 
be viremic at birth. It is suggested that BVD virus penetrates the 
placental barrier during pregnancy and inhibits development of cells 
undergoing mitotic cellular division (Archbald, 1979). Margolis 
et al. (1967) indicated that the external germinal layer of the 
developing cerebellum represents a strategic area for cause of fetal 
death by antimitotic agents such as viruses. The lack of reparative 
potential of these particular tissues has been noted as a cause of 
the terminal destructive process. Kahrs (1973) stated that the 
outcome of fetal BVD infection is probably determined by factors 
of chance, gestation age, the strain of virus and multiple unela­
borated biological variables. Approximately one of every 1000 bovine 
pregnancies is wasted by BVD in the northeastern United States, but 
these losses are not distributed normally throughout the entire 
population of pregnant cattle (Kahrs, 1973).
Fetal Mummification and Resorption Due to BVD Infection
Fetal death during gestation results in termination of 
pregnancy. The outcome of the pregnancy is determined by the stage 
of development of the fetus at the time of fetal death (Archbald,
1979). Fetal death after 6 weeks of gestation usually results in 
abortion, fetal maceration or mummification, whereas if fetal death 
occurs prior to 6 weeks of gestation fetal resorbtion usually is 
observed.
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Scott et al. (1970) showed that fetal mummification occurred 
when BVD virus was inoculated in a heifer pregnant 107 days. This 
heifer was serologically negative for BVD antibody and serocon­
version was noted at 8 days post-inoculation. Leukopenia and a rise 
in body temperature were observed following the inoculation of virus. 
Placental membranes were observed at 180 days post-inoculation and 
a mummified fetus was manually removed. The estimated age of the 
fetus upon removal was 135 days, and the time of fetal death was 
calculated to be between 14 and 42 days.
Kendrick (1971) reported that experimental inoculation of 
23 pregnant cows of various gestation lengths resulted in one case 
of a mummified fetus. The mummified fetus in this study was removed 
by cesarean section, after inoculation of the virus on the 81st day 
of gestation. On the basis of fetal age determination upon removal 
at 40 days post-inoculation the approximate time of fetal death was 
between 9 and 19 days post-inoculation.
Since BVD virus isolation techniques failed to demonstrate 
BVD virus association with either case of mummified fetus, the possi­
bility that a BVD virus infection caused fetal death can only be 
circumstantial evidence. Cases of mummified fetus are commonly 
associated with uterine resorption of fetal membranes and fetal 
fluids. Archbald (1973) suggested that BVD infection of cows during 
early pregnancy may cause fetal resorption.
Since the time sequence between estimated fetal death in cases 
of mummified fetus coincided with the time of BVD infection, whether
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natural or experimental, the hypothesis that the BVD virus can cause 
mummification in pregnant cattle is appropriate.
BVD Infection as a Cause of Infertility
The form of BVD infection that most commonly causes the vast 
majority of reproductive failures is undiagnosed or unreported.
These inapparent BVD infections occurring in susceptible cattle 
result in a biphasic temperature elevation and mild leukopenia.
Ovaritis, or inflammation of the ovary, has been indicative 
of infertility in beef heifers. Miller and Campbell (1978) reported 
that 85 percent of 168 infertile heifers had lesions indicating some 
type of inflammation. Pregnant heifers were also found with ovaritis, 
but the severity was not great as in the infertile heifers. In an 
attempt to diagnose the cause of the lesions, Summers et al. (1974) 
showed no significant relationship of antibody titers to Brucella 
abortus, Leptospira interrogans, serovars, pomona and hardjo; 
Camplyobacter fetus or infectious bovine rhinotracheitis. Ssentongo 
(1980) processed ovaries from 368 infertile heifers from four herds 
of which 78 percent of the cattle showed positive titers to BVD. A 
total of 12 BVD virus isolates were found from the ovarian emulsions. 
One cytopathic virus isolate of BVD was inoculated at its first sub­
passage into eight BVD antibody-free non-pregnant heifers. Ovari­
ectomy was performed after a 61 day period in order to observe 
histological changes after infection. All inoculated heifers 
experienced seroconversion 15 days post-inoculation and a profuse 
interstitial ovaritis was found in 100 percent of the heifers.
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Direct intrauterine infusion of the BVD virus into cows at 
estrus produced a localized infection of the uterus and uterine tube 
(Archbald et al., 1973; Archbald and Zemjanis, 1977). Pregnancy 
rates of cows inoculated with BVD virus prior to insemination at 
12 hours post-estrus were lower (24%) than controls inoculated 
with virus carrier vehicle and inseminated with identical semen (66%). 
Similarly, BVD virus when added to semen caused a mild metritis in 
inseminated heifers (Archbald et al., 1973). A considerable number 
of repeat-breeding animals have associated uterine infection, and 
histopathological examination revealed a greater incidence of uterine 
inflammatory changes in infertile than in fertile animals (Zemjanis,
1980). Observations of superovulated donor cows with varying degrees 
of endometritis indicated that uterine infection does not inhibit 
fertilization rate of ova (Archbald, 1976). It is recognized in the 
studies by Archbald and Zemjanis (1977) that infertility was probably 
caused by direct virus effect on the embryo or ova or indirectly by 
the inflammation of the uterus.
It appears that BVD virus infections, whether acute, chronic 
or sub-clinical, can affect reproductive efficiency at all stages of 
reproduction. Zemjanis (1974) has reported a high incidence of 
embryonic mortality in two herds of cattle with histories of BVD 
infections. Lambert (1973) has indicated that a lowered conception 
rate follows BVD vaccination with modified live virus vaccines.
Archbald (1973) has demonstrated that BVD serum-neutralization 
antibody and the specific anti-BVD virus properties of uterocervical
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secretions are incapable of protecting the uterus and uterine tubes 
after intrauterine inoculations of BVD virus. Possibly direct 
placement of the inoculum in the uterine lumen bypassed the natural 
defense mechanism of the cervix (Archbald, 1973). Edwards (1968) 
showed that when serum neutralization antibodies are present in 
high titers in the serum the transport may only be slight into 
the uterus and uterine tube fluids.
In a later study, Archbald and Zemjanis (1977) demonstrated 
that inoculation of the uterine body and each uterine horn with 
BVD virus followed by artificial insemination resulted in lowered 
pregnancy rates. Pregnancy rates for control cows was 66 percent, 
compared to 24 percent for virus-inoculated cows. Viral isolations 
were found, as reported by Archbald (1973) in uterine tissue. This 
finding supports the hypothesis that BVD positive serum titers and 
uterocervical secretions with anti-BVD activity are incapable of pro­
tection in the uterus and uterine tubes. Inoculated uterine tissue 
examination showed changes of focal mononuclear cell infiltration of 
the submucosa and arteritis of the endometrium, but ulceration and 
necrosis of epithelium of the uterus and uterine tube were not 
observed in tissues from which BVD virus was isolated. Suggested 
explanations of the lowered pregnancy rates were suggested as 
being (1) a result of impaired fertilization by areas in the uterus 
of localized infection or (2) the virus inoculation caused death of 
the developing embryo via localized infection or (3) direct virus
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action on the embryo. Since the non-pregnant inoculated cows 
returned to estrus with no alteration or extension of previous 
estrous cycle lengths, it was assumed the embryo was affected in 
some manner prior to maternal recognition of pregnancy.
More supportive evidence that the virus infection may impede 
ova or embryonic development prior to maternal recognition of preg­
nancy was demonstrated by Archbald (1977). BVD virus was quantified 
by virus isolation procedures from the uterocervical secretions of 
a cow which had failed to conceive after repeated attempts of 
artificial insemination. Subsequent estrous cycles were regular 
and consistent and the suggested cause for this repeat-breeder 
syndrome was embryonic death or lack of fertilization. This cow 
was detected from a herd of Holsteins which experienced abor­
tions, fetal mummification and infertility apparently caused by 
clinical BVD infections. According to Archbald (personal communi­
cation) , BVD virus does not interfere with fertilization but may cause 
embryonic death between eight and sixteen days after breeding.
Congenital Defects of Calves Following BVD Infection
Bovine viral diarrhea (BVD) infection of susceptible pregnant 
cattle can be followed by normal calving, or by abortion, still­
births, mummified fetuses or birth of calves with various congenital 
defects (Kahrs, 1973).
One of the most common congenital defects caused by in utero 
BVD infection is cerebellar hypoplasia (Ward, 1969; Ward et al., 1969;
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Kahrs, 1970; Kahrs et al., 1970a; Kahrs et al., 1970b; Brown et al., 
1973; and Scott et al., 1973). The cerebellar hypoplasia defects of 
newborn calves are characterized by neurologic defects varying from 
slight ataxia to complete inability to stand even though these 
calves usually have normal muscle tone and strength. Severely 
affected calves that are unable to stand usually assume abnormal 
positions. Head tumors and nystagmus are also frequently observed 
in calves suffering from cerebellar hypoplasia. Necropsy of these 
calves show only remnants of the cerebellum. Usually a fluid-filled 
space covered by meninges are found instead of the cerebellum. His­
tological examination usually reveals severe depletion of granule 
cells with clumping of the remaining cells and ectopia of Purkinje 
cells.
Ocular lesions are also commonly associated with congenital 
BVD infections but may not occur in the same calf with cerebellar 
defects (Kahrs, 1980). Bistner et al. (1970) described the histo­
logical changes of ocular defects from calves of dams either naturally 
or experimentally infected with BVD virus. Calves born to cows 
experimentally infected with BVD virus had ocular abnormalities 
consisting of retinal atrophy, optic neuritis, cataract and micro­
phthalmia with retinal dysplasia. Retinal lesions were also seen 
in the calves from naturally-infected cows.
Congenital hydrocephalus in calves has also been associated 
with in utero BVD infections (Markinson, et al., 1976; Axthelm and 
Leipold, 1980; Badman et al., 1981). The principal central nervous
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system malformation associated with BVD infection is cerebellar 
hypoplasia, but Ward (1971) observed that inoculation of BVD virus 
into pregnant sheep on days 22 and 47 of gestation produced lambs 
with hydrocephalus. Hydrocephalic calves have associated cerebellar 
hypoplasia (Badman, 1981) but cerebellar hypoplasia can be observed 
without hydrocephalic defects.
The BVD virus has also been incriminated in other congenital 
defects not associated with the central nervous system. Scott et al. 
(1973) observed brachygnathism of the mandible in calves from 
BVD-infected dams, while Gratzek (1968) demonstrated musculo­
skeletal deformities of calves associated with BVD infections.
Calves with partial alopecia have also been observed after in utero 
BVD infections (Kendrick, 1971).
Viral Infections of Mammalian Preimplantation Embryos
The interaction of the mammalian embryo with viruses is an 
important area of investigation since viruses are known to exist in 
the genital tract (Christian et al., 1965; Virgilio et al., 1965). 
Certain viruses are also known to produce specific congenital defects 
in mammals (Blattner and Heys, 1961; Evans and Brown, 1963; Gordon 
et al., 1964; Medearis, 1964; Ferm and Kilham, 1965; Hardy, 1965; 
Stoller and Colemann, 1965; Williamson et al., 1965; Brown et al., 
1973).
Several investigators have provided ultrastructural evidence 
for the presence of natural oncornaviruses (A- and C-type particles) 
in preimplantation embryos (Enders and Schlafke, 1965; Anderson and
68
Jeppesen, 1972; Chase and Piko, 1973; Kalter et al., 1974a,b). 
Farther investigation of the interactions of some types of virus 
with the preimplantation embryo has revealed that virus like par­
ticles could only be observed in the inner cell mass and not in 
the trophoblast cells (Biczysko et al., 1973). In contrast, Glass 
et al. (1974) injected Newcastle disease virus directly into the 
mouse blastocyst and found large numbers of pleomorphic viral forms 
to be present in the trophoblast while the inner cell mass did not 
show evidence of viral infection. Another important finding by 
Chase and Piko (1973) was that an embryo stage dependency was deter­
mined in the number of virus particles observed in embryos. Viruses 
were not observed in one-cell fertilized oocytes, but were present 
in embryos from the two-cell to blastocyst stage. This phenomenon 
may be attributed to the onset of ribosomal RNA synthesis which is 
initiated at the fertilized one-cell stage (Calarco and Szollosi, 
1973).
The natural significance of oncornavirus particles in germ 
cells and preimplantation embryos is not well understood, but does 
seem to indicate vertical transmission, via either the female or 
male gametes (Bowen, 1979). Evidence of the vertical transmission 
of virus from mother to young is reported by Tuffrey et al. (1972). 
Embryos recovered from mice within a colony of mice in which Sendai 
virus infection was endemic were frequently degenerate; whereas, 
embryos from an adjacent colony which was free of Sendai infection 
were normal. Another report of virus which can apparently cause
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natural infection of preimplantation embryos is lymphocytic 
choriomeningitis virus. Mims (1966) has demonstrated that infected 
mice harbor the virus in essentially all cells, including the gonads, 
and the viral antigen has been identified in the cumulus cells and 
in some mature oocytes. The exact mechanism for vertical trans­
mission has not been determined, but previous evidence indicates 
that oocytes are infected prior to ovulation.
Gwatkin (1963) first reported the experimentally-induced 
viral infection of a mammalian preimplantation embryo. He noted 
that in vitro exposure of two-cell mouse embryos to Mengo encepha­
litis virus significantly decreased the number of embryos which 
developed to blastocysts. In that study, the zona pellucida was 
not an effective barrier to the virus, contrary to the postulation 
by Austin and Lovelock (1958). Antiserum against the Mengo virus 
added to the virus suspension prior to in vitro incubation with 
embryos completely prevented the inhibitory action of the virus on 
the development of the embryos (Gwatkin, 1963). Gwatkin (1964) 
showed that Mengo encephalitis virus was actually replicating in 
the embryos after exposure to the virus in vitro. He also pointed 
out that virus penetration of the zona pellucida was complete within 
10 minutes or less and virus synthesis was also found to occur in 
the unfertilized ovum.
The interaction of oncogenic deoxyribonucleic acid (DNA) 
viruses with preimplantation embryos has been studied by several 
investigators. Brackett et al. (1971) found that although intact
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Simian virus 40 (SMV40) did not absorb to rabbit spermatozoa, isolated 
SVM40 DNA was taken up by spermatozoa. The failure to remove this 
DNA after treatment with deoxyribonuclease indicated that the viral 
genome was probably internalized in some manner by the sperm and 
not merely absorbed on the surface. Does were inseminated with 
spermatozoa exposed to SMV40 DNA and fertilized embryos were recovered. 
Cocultivation of these ova with cell cultures allowed recovery of 
the infectious virus. Baranska et al. (1971) using similar tech­
niques, found infectious SMV40 virus or SVM40 DNA could be recovered 
from previously exposed unfertilized ova, two-cell embryos and 
of mice. Biczysko et al. (1973) exposed two-cell mouse embryos, 
blastocysts and egg cylinders to SMV40 and Polyoma viruses. Uptake 
of SMV40 but not Polyoma virus was found in two-cell embryos, while 
blastocysts and egg cylinders were found to absorb and take up both 
viruses. Replication of Polyoma and SMV40 observed by electron 
microscopy was observed in all stages of embryos and the mechanism for 
uptake in all embryos was by endocytosis. The zona pellucida did 
effectively prevent penetration by both viruses in this study.
Viral infections of early embryos can be experimentally 
induced in vitro or in vivo by exposure of embryos to virus.
Neighbors (1978a) utilized both techniques in studies on the suscep- 
tability of the mouse preimplantation embryo to infection with 
Cytomegalovirus. The preimplantation embryos exposed to Cytomegalo­
virus in vitro developed normally to the blastocyst stage and there
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was no evidence of embryonic infection. Intraperitoneal inocula­
tion of female mice with this virus produced an acute generalized 
infection, and embryonic development was retarded in vivo. The 
embryos from in vivo infected mice developed into normal fetuses 
when transferred to uninfected mice. The failure to infect early 
mouse embryos by either in vitro or in vivo techniques with Cyto­
megalovirus indicates some indirect consequences of the maternal 
disease. Neighbor (1977) showed that acute, localized Cytomegalovirus 
infection of the uterus, induced by intrauterine inoculation of the 
virus on the day of mating, also retarded preimplantation develop­
ment without causing productive embryonic infection. In another 
study by Neighbors (1978b), Cytomegalovirus excreted in semen of 
infected male mice did not produce a productive infection in pre­
implantation embryos when added to an in vitro fertilization system.
Research input concerning virus interactions upon bovine 
preimplantation embryos are limited. Archbald et al. (1979) inocu­
lated the right uterine horn of five Holstein cows 7 days after 
artificial insemination with BVD virus. Embryos collected 3 
days post-inoculation from infected uterine horns were degnerate. 
Electron microscopic examination of the degenerative embryos from 
the infected uterine horns demonstrated the presence of a structure 
which morphologically resembled the BVD virus. Preliminary results 
indicated that the presence of BVD virus within the uterine horns 
may interfere with normal development of preimplantation bovine 
embryos.
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Embryo Transfer as Technique for Controlling Transmission of Viral 
Diseases
Embryo transfer is now a recognized procedure in cattle, pigs, 
sheep, goats and horses (Betteridge, 1977). Generally used in com­
bination with superovulation, embryo transfer has been promoted as a 
means of genetic improvement, introducing new bloodlines into closed 
herds, obtaining offspring from infertile female animals and conduc­
ting research in all species. Relatively little attention has been 
given to the potential role of embryo transfer in the control of 
infectious diseases. However, it has been recommended as a useful 
technique for the rapid establishment of minimal disease herds from 
a few animals with superior genetic backgrounds, or the introduction 
of disease free animals with a different genetic background into 
established minimal disease or closed herds (Curnock et al., 1976).
The collection of uninfected embryos from infected parents 
for transfer to uninfected recipients would be one approach to the 
control of infectious diseases (Eaglesome et al., 1980). Normally, 
when a particular disease is endemic on a farm and the farmer decides 
to eliminate the disease from his herd, the recommendation would be 
to slaughter the animals, disinfect the premises and restock with 
disease free animals. This approach would involve the loss of val­
uable blood lines and years of work. If it could be shown that the 
etiological agent is not transmitted from either parent to the embryo, 
a different approach such as embryo transfer with superovulation 
might offer a workable, more economically rational alternative.
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Waters (1981) has suggested several techniques for processing 
of embryos for health certification of livestock. Techniques indi­
cated were health certification of the genetic sire, and dam, 
transfer procedure, transport medium as well as a health certification 
of the recipient following implantation before embryos can be trans­
ported internationally. The United States Department of Agriculture 
(USDA) has not established specific standards for disease control for 
exportation of embryos from the United States, with only the require­
ments for disease prevention standards of the importing country must 
be met prior to shipment.
Experimentation on the effect of virus interaction with 
mammalian embryos is mainly limited to laboratory animals and swine. 
Wrathall and Mengeling (1979a,b) indicated that porcine parvovirus 
significantly lowered in vitro development of pig embryos exposed 
to virus, and virus was identified on the periphery of the zona 
pellucida of infected embryos. When parvovirus-exposed embryos 
were transferred to seronegative gilts for 8 days and subsequently 
recovered, embryonic retardation was evident and the recipient gilts 
seroconverted to positive status. Further research by Wrathall and 
Mengeling (1979b) showed that the probable reason for embryo retar­
dation was uterine damage, which was considered a direct result of 
the parvovirus infection.
Another experimental use of embryo transfer to control 
disease transmission was demonstrated by Bolin et al. (1981).
Embryos were experimentally infected with pseudorabies virus both 
in vitro and in vivo. Serologic evidence of pseudorabies virus 
transmission was found in recipients in both in vitro and in vivo 
exposed embryos, but pigs born to recipients did not show evidence 
of exposure to pseudorabies by serologic testing or fluorescent 
antibody procedures.
Evidence of disease transmission in cattle by embryo trans­
fer is non-existent, but limited in vitro studies may illustrate 
this possibility. Voelkel et al. (1982) attempted to isolate Brucella 
abortus from uterine flushing of brucella-infected donor cattle. In 
that study, Brucella abortus inoculated in the uterus could not be 
recovered in later uterine flushings, embryo holding medium or the 
harvested embryos. Singh et al. (1982a) evaluated the effects of 
Akabane, Bluetongue and Bovine Viral Diarrhea (BVD) virus upon pre­
implantation bovine embryos. After virus exposure, embryos were 
cultured jin vitro for 24-48 h and results indicated that embryonic 
development was not affected in any groups. Also, no infectious 
virus was isolated from any of the embryos. In addition, embryos 
and ova isolated from donors that were seropositive to BVD virus 
were found uninfected with the virus. Immunoglobulins found in 
follicular fluid by Whitmore and Archbald (1977) may provide some 
protection for recently ovulated ova. Because of the protection of 
immunoglobulins, embryo transfer was suggested as a means of con­
trolling the transmission of the viral infections. In later research,
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infectious bovine rhinotracheitis (IBRV) was evaluated in vitro with 
bovine preimplantation embryos (Singh et al., 1982b). IBRV was found 
to have no effect on embryonic development in vitro. Embryos and ova 
isolated from donors seropositive to IBRV were found to be uninfected 
with this virus.
At the present time, there are no guidelines as to which 
agents can be transmitted from parent to offspring either through 
the gametes or from the environment. Before existing regulations for 
the control of disease in the international movement of embryos can 
be relaxed on the sire, dam and herd of origin and before embryo 
transfer can be used as a means to control or eliminate disease in 
a herd or flock, the etiological agent of each disease of concern 
will have to be investigated individually. Before embryos can be 
certified virus free, it must be determined whether the agent in 
question is capable of being transmitted by the zona pellucida-intact 
embryo. Embryo transfer can only be used as a means of controlling 
or eliminating disease if it can be shown that the holding medium or 
embryo itself are not carriers and that the organism will not infect 
the potential recipient animal.
CHAPTER II
IN VITRO CULTURE OF BOVINE VIRAL DIARRHEA (BVD)
VIRUS AND LIVE AND DEAD BOVINE EMBRYOS WITH AND 
WITHOUT AN INTACT ZONA PELLUCIDA: A TRANSMISSION
ELECTRON MICROSCOPIC STUDY
Introduction
Electron microscopy has provided a wealth of valuable infor­
mation relevant to the field of virology. Until the first electron 
micrographs of viruses were obtained in 1939, nothing was known about 
the structure of virus particles. Lwoff, Horne and Tournier (1966) 
proposed a system of virus classification (the LHT system) based on 
the type of nucleic acid contained in the virion. The remaining 
criteria for classification were related to observations using high- 
resolution transmission electron microscopy (TEM). The four charac­
teristics of the LHT system were:
(1) The chemical nature of the genetic material, either DNA 
or RNA, which determined the Subphyla.
(2) The symmetry of the nucleocapsid of the virion: helical,
cubic or binal, which determined the Class.
(3) The covering of the nucleocapsid, whether naked or
enveloped, which determined the Order.
(4) The size of the nucleocapsid, either the diameter of
the helix, or the number of capsomers in the cubic 
system, which determined the Family.
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The ultrastructure of the bovine viral diarrhea (BVD) virus
can be identified by electron microscopy as being from the Togaviridae
family (Palmer and Martin, 1982). BVD is an RNA virus. It contains 
one molecule of a single strand of RNA. BVD virus has a spherical
morphology and ranges in size from 40 to 70 nm. A lipoprotein
envelope is found tightly attached to an icosahedral nucleocapsid 
with a total of 32 capsomers each about 14 nm in diameter. The 
estimated molecular weight of the nucleus of a single BVD virus 
particle is 4 x 10^ daltons (Roberts and Carter, 1976).
TEM also has applications in the rapid diagnosis of virus
diseases (Gibbs et al., 1980). The methodology for such use is 
divided into two stages: (1) demonstrating virus in clinical
material or (2) identifying isolates from tissue culture or similar 
systems. Utilization of TEM in the diagnosis of skin infections 
caused by viruses (small pox: Nagington and Macre, 1965), brain
biopsies of patients with herpesvirus encephalitis (Gardner, 1977) 
and in the nasophayngeal secretion of children and horses with
respiratory disease (Doane et al., 1967) are a few examples of the
flexibility TEM offers in the diagnosis of viral diseases.
The use of TEM for the study of cell structure in mam­
malian preimplantation embryos led to the intriguing and perplexing 
observations of cytoplasmic particles that closely resembled virus 
particles. These natural occuring infections were initially observed 
by Calarco and Szollosi (1973) and aroused considerable attention as
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the involvement of vertical transmission of viruses. Initial demon­
strations of these virus-like particles were found in ova and embryos 
of the mouse (Calarco and Szollosi, 1973), rabbits (Manes, 1973), 
non-human primates (Kalter et al., 1974b) and humans (Kalter et al., 
1973).
The use of TEM has benefited experimental studies utilizing 
in vitro virus infection of mammalian embryo culture systems.
Bicsysko et al. (1973) demonstrated tissue specificity to various 
viruses and uptake of newly synthesized viruses by specific cell 
types.
Although the utilization of TEM for research in virology 
has great advantages, the technique has obvious disadvantages.
Gibbs et al. (1980) reported two disadvantages of the use of TEM 
as a diagnostic tool in viral infection: (1) high virus particle
concentration is needed and (2) the presumptive nature of the assay. 
The extremely small size of the virus particle (% 30-50 nm) poses 
a limitation on the resolving power, and assumed virus particles 
found in specimens are routinely called "virus-like" particles.
More quantitative tests are usually utilized for more accurate 
diagnosis of viral infection; for example,conventional virus 
isolation and immunocytochemical techniques.
The objectives of this experiment were:
1. To demonstrate the presence of the BVD virus in bovine 
embryos following in vitro incubation using TEM and 
virus isolation techniques.
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2. To evaluate the affinity of BVD virus for live and dead 
bovine embryos.
3. To evaluate the ability of the zona pellucida to afford 
protection to the embryo from BVD virus particle 
penetration.
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Materials and Methods
Experimental Embryos. A total of 80 bovine embryos were
collected from crossbred Angus, Hereford and Brahman donor cows
superovulated with 40-45 mg of follicle-stimulating hormone"*"^ (FSH)
administered intramuscularly (IM) in 5 mg injections twice daily
for 4 days. Treatment with FSH began between days 8 and 12 of the
18estrous cycle (estrus = day 0). Prostaglandin F„ , or an analogue
I a
19
of prostaglandin F , was administered at dose levels of 35 mg and 
2a
500 pg, respectively, at 48 hours after the initial FSH injection 
and estrus was expected within 2 days of the injection of the 
luteolytic agent. Donors were inseminated with frozen-thawed semen 
from bulls that were seronegative for BVD and embryos were collected 
non-surgically on days 6.5 to 7.5 following the induced estrus.
The flushing medium utilized in this project was Dulbecco's PBS 
with 2 percent FCS with standard levels of antibiotics and antimycotic 
(appendix table 2). Embryos were morphologically classified at 100 X 
magnification using phase-contrast optics and morphological grading 
scores were assessed. The FDA viability test was utilized to assess 
viability of the embryos. Fluorescence scores of embryos greater 
than 0 were considered live and viable in this experiment. Embryos
17 R
FSH-P , Burns-Biotec, Omaha, Nebraska.
18 RLutalyse (dinoprost tromethamine), Upjohn, Co., Kalamazoo,
Michigan.
19 REstrumate (cloprostenol sodium), Haver-Lockhart, Bayvet 
Division Cutter Laboratories, Inc., Shawnee, Kansas.
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were assigned to four equal treatment groups (20 embryos per treat­
ment). These groups were as follows: (1) Live embryos with an intact
zona pellucida, (2) Live embryos without a zona pellucida, (3) Dead 
embryos with an intact zona pellucida and (4) Dead embryos without a 
zona pellucida.
Zona pellucidae were removed by micro-dissection using a 
20
Leitz micromanipulator fitted with left- and right-handed controls. 
Micro-dissection techniques were employed in a lid of a 100 mm petri- 
dish filled with Dulbecco's PBS supplemented with 10 percent goat 
serum, antibiotics and an antimycotic (appendix table 4). Goat serum 
(GS) was selected as a portein source for embryos to eliminate the 
possibility of unknown contamination with BVD virus neutralizing anti­
bodies in bovine serum (Waters, 1981). Micro-dissection techniques 
were performed under stereomicroscopsy at a magnification of 75 X 
utilizing micro-instruments constructed from glass pipettes. This 
technique enabled removal of the zona pellucida without inflicting 
damage to the cellular mass.
Exposure of Embryos to BVD Virus. Embryos from each treat­
ment group were cultured In vitro with BVD virus in one volume of 
Dulbecco's PBS supplemented with 10 percent GS and one volume of 
Minimum Essential Medium (MEM) containing the BVD virus (appendix 
table 4). The BVD virus (Singer Strain, Lot 4) was originally
20
Leitz Micromanipulator, E. Leitz, Wetzlar, Germany.
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obtained from the USDA National Veterinary Services Laboratory,
(NVSL) Ames, Iowa. The virus was passed once through BVD-free bovine
turbinate cells, which was also obtained from USDA-NVDL, and grown in
4 5
goat serum-enriched MEM. The titer of the stock virus was 10 - 10
Tissue Culture Infective Dose - 50(TCID^^). This titer indicated 
that the BVD virus suspension, diluted to 10-^ to 10  ^and inoculated 
in units of .025 ml, is the highest dilution which infected 50 percent 
of the tissue culture system. Embryos were cultured in a 2 ml volume 
in 35 x 10 mm tissue culture dishes for 24 hours at a constant tem­
perature of 37 C in a humidified air atmosphere. Immediately after 
the 24 hour culture period, the embryos were washed by transferring 
them through three 2 ml volumes of Dulbecco's PBS with 10 percent GS 
(1:400 dilution). A fresh handling pipette was used to transfer the 
embryos to each successive wash. After washing, the embryos were 
assessed as to their morphological classification, morphological 
grade and fluorescence score.
Processing of Embryos for TEM. Immediately following post­
culture evaluation, 40 embryos (10 embryos per treatment) were ran­
domly selected for electron microscopic evaluation. Embryos were 
pre-fixed for 1 hour in 3 percent glutaldehyde in .1 M sodium 
phosphate buffer and then washed three consecutive times in .1 M 
phosphate buffer and left in the final wash at 5 C until further 
processing (appendix table 5). A total of five grids, each with 5-10 
sections from each embryo were evaluated. Demonstrative comparisons
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presented in pictorial form for each treatment group provided ultra- 
structural differences and alterations in the specific location of 
"virus-like" particles.
Processing of Embryos for Viral Assays. Immediately following
post-culture evaluation, the remaining 40 embryos (10 embryos per
21
treatment) were sonificated using a high frequency sonifer in 
replicates of three to four embryos. Three replicates were assayed 
for each treatment group. The sonificated embryos, the BVD virus 
inoculum in which the embryos were cultured, the medium in which the 
embryos were initially washed and a control inoculum in which no 
embryos were cultured, were all subjected to virus isolation pro­
cedures (appendix table 6) and verified by fluorescent antibody 
assay (appendix table 7); as described by Rovozzo and Burke, (1973), 
and Fulton et al., (1982). Samples indicating positive cytopathic 
effects (CPE) were validated as positive for BVD virus with the 
fluorescent antibody technique. Viral isolation procedures were 
initially completed on the medium from the first washing of the 
embryos. If this medium was positive, the second and third washes 
were subsequently assayed. Virus concentration titrations (appendix 
table 8) of control inoculum and the inoculum containing the BVD 
virus in which the embryos were cultured were assayed in order to 
assess levels of the uptake of virus among the treatment groups.
21
Branson Sonifer, Model-200, Danbury, Connecticut.
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Statistical Analysis. Differences in mean values for 
live embryos with an intact zona pellucida and live embryos without 
a zona pellucida for pre-culture and post-culture assessments of 
morphological grades and fluorescence scores were analyzed by Stu­
dents t-test procedure (Steel and Torrie, 1980). The number of 
embryos developing in culture for each treatment group were compared 
by Chi-square analysis.
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Results and Discussion 
Mean values for pre- and post-culture viability indicators 
and percent development of all four treatments groups of embryos are 
shown in table 18. Pre-culture morphological grades and fluorescence 
scores were similar and not significantly different for live embryos 
with and without the zona pellucida. Unfertilized ova were utilized 
in each treatment group for dead embryos with and without zona pellu­
cida, which accounted for pre-culture morphological grades and 
fluorescence scores of zero. Post-culture morphological grades of 
live embryos with and without a zona pellucida were increased when 
compared to corresponding pre-culture assessments, indicating decreased 
viability. Although, no significant differences were found for post­
culture morphological grade between live embryos with a zona pellucida 
and live embryos without a zona pellucida. Post-culture fluorescence 
scores of live embryos with and without a zona pellucida were decrea­
sed when compared with pre-culture fluorescence scores, indicating 
decreased viability. These results are in general agreement with 
those of Chapter I, as culture time was a major source of variation 
in morphological grading and fluorescence scores. Post-culture 
fluorescence scores of live embryos with intact zona pellucida 
were higher than scores of live embryos without zona pellucida, sug­
gesting increased viability. However, this difference was not 
significantly different. Post-culture morphological grades and 
fluorescence scores of dead embryos with and without zona pellucida 
remained unchanged indicating advanced degeneration and no viability.
TABLE 18. MEAN VALUES FOR PRE-CULTURE AND POST-CULTURE VIABILITY INDICATORS 
AND PERCENT DEVELOPMENT OF LIVE AND DEAD EMBRYOS WITH 
AND WITHOUT AN INTACT ZONA PELLUCIDA1
Treatment group n
Pre-
Grade
-culture
Fluorescence
Post
Grade
-culture
Fluorescence
No. of embryos developing 
in vitro % Developing
Live embryos 20 1.65a 3.18 2.00 1.23 15 75%
with a zona + .19 + .26 + .19
pellucida
Live embryos 20 1.65 3.05 2.05 .63 14 70%
without a zona +. 16 + .14 + .26 +.09
pellucida
Student's t-test used to test differences among means, 
^ean plus or minus standard error.
oo
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A total of 15 of 20 (75%) live embryos with an intact zona 
pellucida developed in BVD virus-infected medium after 24 hours, 
while 14 of 20 (70%) of live embryos without a zona pellucida 
developed in culture. Although live embryos without a zona
pellucida developed at a lowered rate than live embryos with an
intact zona pellucida, this difference was not significantly dif­
ferent. These data indicate that embryonic development within the 
BVD virus-infected medium defined was independent of the intact 
zona pellucida. Recently, Bowen et al. (1982) utilized a similar
technique (removal of zona pellucida) of bovine embryos to study
the effect of Bluetongue virus upon embryonic development. This 
study showed that the zona pellucida protected the virus-exposed 
embryos while the zona pellucida free embryos degenerated.
Results of virus isolation, fluorescent antibody and virus 
titration assays of control and BVD virus-infected medium and embryos 
are shown in table 19. Virus isolation procedures were negative for 
sonificated embryos of each treatment group, along with the initial 
wash samples of each of the embryo treatment groups. Singh et al. 
(1982a) found similar results with viral isolation assays of BVD 
virus exposed embryos. Possible explanation for these negative 
assays of sonificated embryos, are offered by Bowen (1979). He 
indicated that due to the very small size of mammalian preimplan­
tation embryos the use of conventional virus isolation assays 
utilizing cell culture may have some definite inadequacies. The
TABLE 19. RESULTS OF VIRUS ISOLATION, FLUORESCENT ANTIBODY AND VIRUS 
TITRATION ASSAYS OF CONTROL AND BVD INFECTED MEDIUM AND
EMBRYOS
Treatment group
Sonificated Initial 
Embryos Wash
Control BVD 
Medium
Control BVD Medium 
With Embryos Difference
Live embryos 
with a zona
_a __ +b ; 10 lc 1 33+ ; 10 -.33
Live embryos 
without a zona 
pellucida
- -- +; 101 + ; 101 0
Dead embryos 
with a zona 
pellucida
+; 101-33 +; 101 .33
Dead embryos 
without a zona 
pellucida
+; 101-33 +; 10l .33
aNegative CPE on virus isolation assay.
^Positive CPE and positive on fluorescent antibody assay.
cTissue Culture Infective Dose - 50 (TCID50^
CD
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possibility that the BVD virus upon interaction with bovine embryos 
were rendered non-infective or that the c.ytopathic effect of the 
virus has changed to a non-cytopathic effect cannot be established 
in the experiment by Singh et al. (1982a) or the present experiment. 
The change of cytopathic effect of BVD virus has been shown in swine 
by Stewart et al. (1971) and Carbrey et al. (1976), while the non­
permissiveness of viruses to mammalian embryos has been reported by 
Neighbour (1978a) and Biczysko et al. (1973).
Attempts to quantitate the uptake of virus by performing 
BVD virus titration assays on control medium (without embryos) and 
BVD virus medium with embryos was unsuccessful in the present experi­
ment. FA tests confirmed active virus in all control and embryo 
cultured medium after the 24-hour culture period, although only 
small and inconsistent differences in virus titrations were found 
between control and virus medium with embryos.
TEM evaluation of embryos in each embryo treatment group 
provided new information as to ultrastructural differences between 
live and dead embryos, each with or without a zona pellucida. Struc­
tures which morphologically resembled the BVD virus were found in 
live embryos with an intact zona pellucida (figures 1, 2 and 3). 
Virus-like particles were found at a greater incidence within the 
cytoplasm of trophoblast cells of blastocysts with an intact zona 
pellucida. The presence of these virus particles provided evidence 
that the BVD virus can penetrate the zona pellucida of bovine embryos.
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Figure 1. A transmission electron micrograph of a section 
from a live embryo with an intact zona pellucida. The presence of 
mitochrondria (M) within the cytoplasm of this trophoblast cell 
may indicate viability in presence of a virus-like structure (arrow) 
that morphologically resembles the BVD virus. Uranyl acetate and 
lead citrate stain; 96,000 X.
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Figure 2. A transmission electron micrograph of a section 
from a live embryo with an intact zona pellucida showing microvilli 
(Mv) and presence of a BVD virus-like structure (arrow). Uranyl 
acetate and lead citrate stain; 96,000 X.
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Figure 3. A transmission electron micrograph of a section 
from a live embryo with intact zona pellucida. Endoplasmic 
reticulum (ER) in the cytoplasm of a trophoblast cell along with 
the presence of a BVD virus-like particle (arrow). Uranyl acetate 
and lead citrate stain; 96,000 X.
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Archbald et al. (1979) demonstrated the presence of a structure 
which morphologically resembled the BVD virus from a zona pellucida- 
intact degenerate embryo which was collected after in utero inocu­
lation with medium containing BVD virus. The presence of the BVD 
virus beneath the zona pellucida is in disagreement with data of 
Singh et al. (1982a) which suggested that the BVD virus was not 
capable of penetrating the zona pellucida. It is important to note 
that the observations of Singh et al. (1982a) were not made by elec­
tron microscopy, but by virus isolation assay. This discrepancy may 
be due to the fact that the small amounts of viral particles which 
penetrated the zona pellucida was below the limit of detection of 
the virus assay.
Figure 4 depicts a virus-like particle that resembles the 
BVD virus within the inner cell mass of a live embryo without a 
zona pellucida. The presence of this virus particle demonstrated 
that the BVD virus may have no tissue specificity as to infection 
of bovine embryos. Biczysko et al. (1973) reported that virus-like 
particles could only be observed in the inner cell mass and not in 
the trophoblast cells, while Glass et al. (1974) using Newcastle 
disease virus found no virus in the inner cell mass although eval­
uation of the trophoblast revealed the virus.
BVD virus-like particles were also observed in other live 
embryos without a zona pellucida within the cytoplasm of a tropho­
blast cell (figure 5).
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Figure 4. A transmission electron micrograph of a section 
from a live embryo without a zona pellucida. The BVD virus-like 
particle (arrow) is shown in association with the inner cell mass 
(ICM). The blastocelic cavity (Be) is indicated for orientation. 
Uranyl acetate and lead citrate stain; 170,000 X.
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Figure 5. A transmission electron micrograph of a section 
from a live embryo without a zona pellucida showing a virus-like 
structure (arrow) that morphologically resembles the BVD virus.
This transmission electron micrograph was taken within the cyto­
plasm of a trophoblast cell. Uranyl acetate and lead citrate stain; 
192,000 X.
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Ultrastructural observations of each treatment group including 
live embryos, with and without zona pellucida gave no indication of 
cellular degeneration. Abundant mitochrondria containing low electron- 
dense matrices and stacked, laminar cristae were present in all sec­
tions observed. Identification of endoplasmic reticulum and large 
nucleus with prominent nucleolus and distinct nuclear membranes sug­
gested that cellular mechanisms were probably not affected adversely 
by the presence of the BVD virus. Virus-like particles have been 
observed in mouse embryos without any evidence of cellular degenera­
tion of the associated organelles (Van Blerkom and Motta, 1979).
Observations of dead embryos with and without zona pellucida 
by TEM (figures 6 and 7) revealed cytoplasmic degeneration and abun­
dance of granular and myelinated figures. No virus-like particles 
resembling the BVD virus were observed in any of the dead embryos- 
with or without the zona pellucida.
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Figure 6. A transmission electron micrograph of a section 
from a dead embryo with an intact zona pellucida. The electron 
dense zona pellucida (ZP) surrounds the granulated cytoplasm. 
Uranyl acetate and lead citrate stain; 49,500 X.
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Figure 7. A transmission electron micrograph of a section 
from a dead embryo without a zona pellucida coarse granulation and 
vesiculation of the cytoplasm; (*) indicates the absence of the 
zona pellucida. Uranyl acetate and lead citrate stain; 65,000 X.
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CHAPTER III
DEVELOPMENT OF THE BOVINE BLASTOCYST FOLLOWING 
MICRO-INJECTION WITH BOVINE VIRAL DIARRHEA
Introduction
Interest in the effect of viruses on mammalian development has 
largely focused on teratology, with experimental studies primarily 
devoted to the fetus after implantation. This area of concern was 
most intensively researched because the mammalian embryo prior to 
the implantation stage is thought to be almost impervious to tertato- 
genic agents (Wilson, 1965).
Inconsistent reports have suggested that some virus particles 
can penetrate the zona pellucida and arrest development of mouse 
embryos. Research with other viruses has indicated that the zona 
pellucida was impervious, and this has led to the accepted method 
of studying viruses associated with embryos following removal of the 
zona pellucida.
BVD virus has been reported to be unable to penetrate the 
zona pellucida of bovine embryos (Singh et al., 1982a). This 
finding was not obtained from electron microscopic evaluations 
but from viral assays. Substantial amounts of viral particles must 
be present for the viral assay system to be positive. This high 
level of assay sensitivity may not account for a small amount of 
viral particles that may be able to penetrate the zona pellucida.
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In order to infect intact preimplantation embryos with a 
virus, techniques of micro-injection were incorporated in this 
experiment. Linn (1966) developed a method of injecting fertilized 
one-cell mouse ova, by the use of a Leitz micromanipulator "egg- 
holder" pipette and a small injection pipette. The small diameter 
of the injection pipette (1 ym) was used to pierce the elastic zona 
pellucida and vitelline membrane of mammalian embryos. Lin and 
Monie (1973) reported no reduction in survival of micro-injected 
mouse blastocysts when compared with non-injected control blasto­
cysts. Glass et al. (1974) used the technique developed by Linn 
(1966) to study the effect of Newcastle disease virus using mouse 
embryos. Injection of the virus directly into the blastocoele 
resulted in 71 percent degeneration of the blastocysts while 93 
percent of the injected controls (without virus) developed in vitro 
and appeared normal.
The objectives of this experiment were:
1. To evaluate survivability of bovine blastocysts in an 
in vitro culture system after penetration of the zona 
pellucida, vitelline membrane and trophoblast membrane 
using micro-injection techniques.
2. To inject BVD virus directly into the blastocelic cavity 
of bovine blastocysts using micro-injection techniques 
with subsequent culture as an indication of embryo 
viability.
108
Materials and Methods 
Experimental Embryos. A total of sixty bovine blastocysts 
were collected from crossbred Angus, Hereford and Brahman donor
22cattle superovulated with 40-45 mg of follicle-stimulating hormone
(FSH) administered intramuscularly (IM) in 5 mg injections twice
daily for four days. Superovulatory treatment began on days 8-12
23
of the estrous cycle (estrus = day 0). Prostaglandin F 2 a > or an
24
analogue of prostaglandin F^^ , was administered IM 48 hours after
the initial FSH injection and estrus was expected within two days 
of the administration of the luteolytic agent. Donors were insemi­
nated with forzen-thawed semen from bulls that had been tested and 
found seronegative for BVD virus. Non-surgical embryo recovery was 
employed 7.5 days after the first insemination of the donor.
Embryos were flushed from the donor's uterus with Dulbecco's 
PBS with 2 percent FCS containing antibotics and an antimycotic 
(appendix table 2). Blastocysts and expanded blastocysts were 
morphologically classified and assessed morphological grading scores 
using phase-contrast optics (100 X). Fluorescence scores were 
assessed as described in Chapter I. Only blastocysts of morpho­
logical grades less than or equal to 2, with fluorescence scores 
of 3 or greater were utilized in this experiment.
22 R
FSH-P , Burns-Biotec, Omaha, Nebraska.
Lutalyse (dinoprost tromethamine), Upjohn Co., Kalamazoo,
Michigan.
n /
Estrumate (cloprostenol sodium), Haver-Lockhart, Bayvet 
Division, Culter Laboratories, Inc., Shawnee, Kansas.
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Measurements were made of the diameter of each blastocyst's cellular
mass, excluding the zona pellucida, by the use of a calibrated ocular 
25
micrometer. Measurements were converted to microns by determining 
that an ocular micrometer reading of 129 equaled a distance of 100 
microns. Blastocysts were randomly assigned across donors to three 
treatment groups (20 blastocysts per treatment). The treatment 
groups were as follows: (A) control blastocysts, no injection;
(B) control blastocysts injected with medium without BVD virus and
(C) blastocysts injected with medium containing BVD virus.
Micro-injection of Blastocysts. Prior to micro-injection
procedure, embryos were held individually in 35 x 10 mm petri-dishes
filled with Dulbecco's PBS with 10 percent fetal-calf serum (FCS),
and antibiotics and an antimycotic (appendix table 9) at 22 to 24 C.
For micro-injection manipulation blastocysts were transferred to
a 2 ml drop of control medium (Treatment B) consisting of Dulbecco's
PBS + 10 percent Goat Serum (GS) (appendix table 4) or a 2 ml drop
3.5
of Dulbecco's PBS + 10 percent GS medium containing 10 ' TCID^
per .025 ml of BVD virus (Treatment C). Each blastocyst was
securely immobilized by a smooth suction pipette held by the
26
left-hand Leitz micro-manipulator arm, which was connected by 
silastic tubing to a screw-syringe. The micro-injection pipette 
was held in place by the right-hand Leitz micro-manipulator arm.
O C
Ocular Micrometer, Baush and Lomb, Rochester, New York.
26
Leitz Micromanipulator, E. Leitz, Wetzler, Germany.
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The micro-injection pipette was connected by non-expandable poly-
27
ethylene tubing to a 1 ml Hamilton glass syringe that was dis­
placed by a sensitive micrometer. Low viscosity paraffin oil was 
filled throughout the Hamilton syringe, polyethylene tubing and 
throughout the injection pipette. Injection medium was aspirated 
into the injection pipette by negative pressure in the calibrated 
syringe and displaced by turning the micrometer at consistent 
volumes. Using the micro-injection pipette which was tapered over 
a length of approximately 1.5 cm to a diameter of 3 ym at the tip 
approximately .0022 yl of medium (either control or BVD virus 
suspension) was injected directly into the blastocoele by piercing 
the highly elastic zona pellucida, vitelline and trophoblastic 
membranes. Care was taken to avoid the inner cell mass of the 
blastocysts. Treatment A blastocysts remained in individual 
dishes in Dulbecco's PBS with 10 percent FCS until all other 
treatment embryos were processed. Blastocysts in Treatment B were 
treated before those in Treatment C to prevent contamination by the 
experimental use of BVD virus since the same injection pipette 
was utilized for each series. Treatment C blastocysts were washed 
three successive times in medium of PBS with 10 percent FCS after 
injection with BVD virus.
In Vitro Culture Procedures. Evaluation of survival of 
all blastocysts were assessed by in vitro culture for 48 hours.
27Hamilton Glass Syringe, Hamilton Co., Whittier, California.
Ill
Blastocysts were individually cultured in Ham's F-10 medium supple­
mented with 10 percent FCS (appendix table 9 ) at 37°C in a humidified 
atmosphere of 5 percent CO 2  in air (Wright et al., 1976a,b). Develop­
ment of blastocysts in culture was evaluated at 24 h intervals at 
100 X using phase-contrast and fluorescent microscopy. Blastocysts 
were initially transfered to individual petri-dishes (35 x 10 mm) 
with Dulbecco's PBS with 10 percent FCS and morphological classi­
fication, morphological grade, fluorescence and size of the cellular 
mass were assessed. Resulting positive or negative morphological 
development was also determined by evaluating progression in embryo 
stage from previous evaluations. Blastocysts were returned to fresh 
Ham's F-10 medium and replaced in a 37°C humidified atmosphere 
of 5 percent CO2  in air for an additional 24 h of culture. Eval­
uation was repeated at the end of the 48 h culture period and 
blastocysts were fixed for transmission electron microscopic eval­
uation as described in Chapter II.
Statistical Procedures. The analysis of variance proce­
dures of SAS 79 was used for the analysis of the data and Duncan's 
Multiple Range Test was used to test differences among means.
Resulting development in culture, morphological grade, fluorescence 
and size of blastocysts were analyzed using a split plot design with 
treatments (A, B and C) as the main effect and time in culture (0,
24 and 48 h) as the sub-unit.
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Results and Discussion
Analysis of variance (table 20) indicated that treatment 
was not a source of significant variation for development, grade, 
fluorescence or diameter of cell mass parameters of experimental 
blastocysts. Significant variation was indicated in the time in 
culture for all parameters of experimental blastocysts for develop­
ment, grade, fluorescence and diameter of cell mass. The time by 
treatment interaction was not a significant source of variation 
indicating that the responses due to treatment did not change over 
time of the culture period.
Means for percent development in culture, assessments for 
grade and fluorescence and diameters of cell mass of treated 
embryos are shown in table 21. Developmental rates of blastocysts 
were similar for all treatments, although blastocysts which were 
micro-injected with BVD virus (Treatment C) tended to develop at 
the highest rate. Similar results were also found between the three 
treatments for grade assessments, although Treatment C blastocysts 
had the lowest grade assessments indicating higher quality. Fluo­
rescence scores of Treatment C blastocysts were also higher than 
both Treatment A and B blastocyst but means were similar. Diameter 
of cell mass of microinjected control blastocysts were larger than 
either non-injected control blastocysts (Treatment A) or BVD virus 
injected blastocysts (Treatment C). Non-injected control blasto­
cysts (Treatment A) had the smallest diameter of cell mass. Micro­
injected blastocysts of both Treatments B and C tended to hatch
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TABLE 20. ANALYSIS OF VARIANCE FOR PERCENT DEVELOPMENT, 
GRADE, FLUORESCENCE AND DIAMETER OF CELL MASS
OF MICRO-INJECTED AND CONTROL EMBRYOS
Mean squares
Source df Development Grade Fluorescence Diameter
Treatment  ^
Embryo (Treatment) 
Time
Time x Treatment 
Error b
2
57
2
4
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.067 
.101 
1.550** 5 
.067 
.082
.235
.744
.705*
.288
.566
.422
.181
220.176**
.168
.213
10587.308
4511.425
106866.320**
1878.371
1780.762
1
error a.
**P < .01.
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TABLE 21. MEAN PERCENT DEVELOPMENT, GRADE, FLUORESCENCE, 
AND DIAMETER OF CELL MASS OF TREATMENT 
EMBRYOS AVERAGED OVER TIME
Treatment (n) Development Grade Fluorescence Diameter3
A2 60 88.335 1.43 1.32 170.69
+1.30 + .30 +.02 +229.89
B3 60 85.00 1.49 1.38 197.11
+1.30 + .30 +.02 +229.89
C4 60 91.67 1.36 1.48 181.49
+1.30 +.30 +.02 +229.89
^"Diameter of cell mass measured in micrometers (ym) .
2
A = control blastocysts, no injection.
3
B = control blastocysts injected with medium without BVD virus.
4C = blastocysts injected with medium containing BVD virus.
3Mean plus or minus standard error.
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through the point of puncture of the zona pellucida than non-injected
blastocysts during the 48 hour culture period, which probably account
for the larger diameter of the cell mass when evaluated. Negative
effects were not observed in blastocysts injected with .0022 pi of
3.5
BVD virus (10 * TCID^q /.025 ml) for development in culture, grading
or fluorescence assessments and diameter of cell mass as compared to 
blastocysts injected with control medium or non-injected control 
blastocysts during the 48 hour culture period. Transmission elec­
tron microscopic evaluation of BVD virus injected blastocysts 
revealed virus-like particles which morphologically resembled the 
BVD virus in close association with the trophoblastic membranes 
(figure 8).
Means for percent development, grade, fluorescence and 
diameters of cellular mass of blastocysts at 0, 24 and 48 hours of 
in vitro culture as shown in table 22. As time increased blasto­
cyst development decreased. Blastocyst development was significantly 
reduced at the 48-h evaluation as compared with the 24- and 0-h 
evaluation, which were not significantly different. Grade assess­
ments were significantly increased, indicating reduce blastocyst 
viability at the 48 h evaluation, although grade assessments were 
not different at the 24 h and 0 h assessment. Mean fluorescence 
scores also decreased significantly as time increased. Fluores­
cence scores of blastocysts were higher upon initial evaluation (Oh) 
and were significantly reduced at each 24 h increments of evaluation.
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Figure 8. A transmission electron micrograph of a section 
from a hatched blastocyst 48 hours after micro-injection with BVD 
virus. A BVD virus-like structure is shown within the cytoplasm 
of a trophoblast cell. Uranyl acetate and lead citrate stain; 
204,800 X.
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TABLE 22. M E M  PERCENT DEVELOPMENT, GRADE, FLUORESCENCE 
M D  DIAMETER OF CELL MASS OF MICRO-INJECTED 
M D  CONTROL EMBRYOS AFTER CULTURE FOR 
48 HOURS AT 37 C1
Time n Development Grade Fluorescence
2
Diameter
0 h 60 1 0 0 .ooa3 1.23a 3.59a 137.00a
+1.05 + .07 + .02 +229.8
24 h 60 95.00a 1.26a . 51b 192.48b
+1.05 + .07 + .02 +229.8
48 h 60 70.00b 1.78b .07° 219.83C
+1.05 +.07 + .02 +229.8
^Means combined over treatments.
2
Diameter of cell mass measured in micrometers (ym).
O
Mean plus or minus standard error.
a,b,cValues in the same column with different superscripts 
differ (P < .05).
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At the 48 h evaluation, less than 15 percent of the cultured blasto­
cysts showed fluorescence. Mohr and Trounson (1980) have shown 
that 50 percent of the initial intracellular fluorescein was lost 
in 30 minutes at 37 C and less than 5 percent remained after 2 hours. 
Loss of fluorescence was not considered as an indication of decrea­
sing blastocyst viability since long incubation times were employed 
in the present experiment. Blastocyst diameter of cell mass were 
significantly higher at each 24 h evaluation, indicating blastocyst 
growth throughout the 48 h culture period. The increased diameter 
of cellular mass also indicated optimum culture techniques were 
employed along with the fact that 73 percent of all blastocysts 
began or completed hatching from the zona pellucida. Wright 
et al. (1976a,b) have shown that in vitro cellular growth and 
hatching were associated with optimum culture techniques. Diameter 
measurements of experimental blastocyst in this study were similar 
to previously reported values of 7.5 day old bovine blastocysts 
(Hamilton and Laing, 1946; Chang, 1952; Olds et al., 1968). Further­
more, no reduction in development was indicated by micro-injection 
and culture techniques developed in this experiment. In this study, 
viability indicators were utilized during a 48 hour culture period, 
whereas a longer culture time may have revealed different results.
CHAPTER IV
EFFECT OF TRANSFERRING BOVINE VIRAL DIARRHEA 
(BVD) VIRUS-EXPOSED BOVINE EMBRYOS INTO RECIPIENTS
Introduction
To provide conclusive evidence that embryo transfer can 
be used in a disease prevention manner, similar to those techniques 
used routinely by artificial insemination, well designed, controlled 
experimentation must be provided.
BVD virus has been incriminated in abortion, fetal wastage 
and congenital malformation and infertility (Archbald, 1979). In 
utero inoculation of superovulated donor cows resulted in the 
presence of BVD virus-like particles within embryos collected 
three days following infection (Archbald, 1979). Therefore, it 
is theoretically possible to transmit the disease via embryo 
transfer.
Experimentation utilizing embryo transfer into recipients 
as a means for assessing the exposure of an embryo to virus has been 
utilized in mice by Chapman et al. (1974). The resulting fetuses 
were found to contain virus at a high incidence. Wrathall (1979) 
demonstrated that porcine embryos infected in vitro with porcine 
parvovirus (PRV) could transmit the disease to recipient gilts, whose 
serological status was converted and PRV virus was detected in the
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uterine lymph nodes. Also observed in the recipient gilts were 
distinct histopathological changes in the uterine epithelium and 
ovaries, but PRV virus was not isolated from these tissues. Bolin 
et al. (1982) found similar results in embryo transfer studies with 
pseudorabies virus in swine. These researchers infected potential 
embryo donors immediately after mating with intranasal suspensions 
of pseudorabies virus along with a group of non-infected donors 
whose embryos were infected in vitro and transferred. All recip-
g
ients of in vitro infected embryos (10 CCID of pseudorabies virus) 
seroconverted and two of five recipients into which intranasal 
infected donor embryos were transferred also seroconverted. One 
of seven positive recipients farrowed and the piglets, which were 
tested prior to receiving colostrum, showed no evidence of pseu­
dorabies virus infection.
No literature is available that utilizes bovine embryo 
transfer as a means of assessing virus interaction with the embryo.
The outcome of transferring virus-exposed embryos into clean recip­
ients is the ultimate test in the evaluation of embryo transfer as 
a tool in disease prevention (Eaglesome, 1980).
The objectives of this experiment were:
1. To evaluate the pregnancy rate of subsequently trans­
ferred BVD virus-exposed embryos into "clean" recipients.
2. To monitor the serological profiles of each recipient 
after transfer of BVD virus-exposed embryos.
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Materials and Methods
Experimental Embryos. A total of 100 bovine embryos were
collected from crossbred Angus, Hereford and Brahman donor cows
9 Q
superovulated with 40 to 45 mg of follicle-stimulating hormone (FSH)
administered intramuscularly (IM) in 5 mg injections twice daily for
4 days. FSH treatment began between days 8 and 12 of the estrous
29
cycle (estrus = 0). Prostaglandin F„ (35 mg) was administered
2a
at 48 hours after the initial FSH injection and estrus was expected 
within 2 days of the injection of the luteolytic agent. Donors were 
inseminated with frozen-thawed semen from bulls that were seronega­
tive for BVD. Embryos were non-surgically collected on day 7.0 
following the induced estrus. The flushing medium was Dulbecco's 
PBS supplemented with 2 percent FCS with standard concentrations 
of antibiotics and an antimycotic (appendix table 2). Embryos were 
morphologically classified using phase-contrast optics (100 X) and 
morphological grading scores assessed. The FDA viability test was 
utilized to assess fluorescence scores as shown in Chapter I. Only 
morula, advanced morula and early blastocysts of morphological grades 
of 1 and 2 with fluorescence scores of 2 or greater were utilized 
in this experiment. Embryos were randomly assigned to two culture 
systems containing 50 embryos each. The culture systems were:
Control medium consisting of 1:1 combination of Dulbecco's PBS and
28 RFSH-P , Burns-Biotec, Omaha, Nebraska.
29 RLutalyse (dinoprost tromethamine), Upjohn, Co.,
Kalamazoo, Michigan.
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Minimum Essential Medium (MEM) as previously described in appendix
table 4, and the BVD virus-infected medium, which contained the
same constituents as the control medium but included the BVD virus.
Both control and BVD virus-exposed embryos remained in a humidified
air atmosphere at 37 C for 24 hours. The BVD virus used in this
experiment was from the same lot as that described in Chapter II.
The titer of the stock virus used in this culture experiment was 
4 5
also 10 and 10 TCID^q /,025 ml. Immediately after the 24-h culture
period the embryos of each culture system were washed by transferring 
them through three 2 ml volumes of Dulbecco's PBS with 10 percent GS 
(1:400 dilution). A fresh handling pipette was used to transfer the 
embryos to each successive wash. After washing, the embryos were 
assessed for their morphological classification, morphological grade 
and fluorescence score. Morphological development was also deter­
mined by evaluating progression in embryo morphological classification 
from pre-culture evaluations.
Non-surgical Embryo Transfer Procedures. Immediately 
following the post-culture evaluation 60 highest quality embryos 
(30) embryos from each culture system) were selected for transfer
by non-surgical techniques into suitable recipients. Embryos were
30
individually aspirated into .25 ml French semen straws. The 
straws were heat-sealed and placed horizontally in a test tube
30
.25 ml French Straws, M. Cassou, L'Aigle, France.
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surrounded by a 500 ml water jacket for transport to the transfer 
location. Cross-bred beef recipient females were selected from the 
St. Gabriel Experiment Station Physiology Herd, which had not been 
BVD vaccinated. The recipients were naturally exposed to BVD virus, 
and approximately 50 percent were known to have positive antibody 
titers for BVD prior to the beginning of the experiment. Recipients 
were observed twice daily for estrus activity. Appropriate recipients 
had at least two previous estrous cycles of 18 to 24 days. Recipients 
were considered in synchrony when estrus, either natural or synchro­
nized, was within a range of 4 days of the donor's estrus being 
the mean of the 4 day period. Non-surgical transfers were made 
during the months of May through August, 1982. Recipients were pre­
pared for non-surgical transfer initially by rectal examination of 
each ovary in order to characterize ovary size, folliclar develop­
ment and consistency and location of the corpus luteum which
corresponded to the particular day of estrous. Epidural injection
31of 3 to 5 ml of Carbocaine between the last sacral and first 
coccygeal vertebrae caused relaxation of rectal contractions which 
aided in palpation of the reproductive tract.
Straws containing the control and BVD virus-exposed embryos
32were placed into a Cassou inseminating gun, the heat-sealed end 
cut and a 46 cm outer sheath slipped over the end of the straw-gun.
31
Carbocaine, Winthrop Laboratories, New York, New York.
32
Cassou Inseminating Gun, M. Cassou, L'Aigle, France.
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A 23 cm plastic drinking straw with one end covered by plastic coated 
paper was then slipped over the end of the straw gun and a 12 cm 
hemostat was attached to the open end of the drinking straw for a 
handle. The entire apparatus was inserted into the vagina of the 
recipient female and manipulated into the external £s of the cervix 
where the Cassou apparatus was forced through the plastic, coated 
paper barrier on the end of the drinking straw. The Cassou appa­
ratus was then passed through the cervix and up into the uterine 
horn ipsilateral to the ovary with the functional corpus luteum. 
Recipients that have received BVD virus-exposed embryos were iso­
lated for the entire length of the project.
Virus Isolation and Serologic Testing. In order to verify 
that active virus was present during the culture period, both the 
control and BVD virus-infected culture medium were assayed for 
cytopathic effects (CPE) following growth on bovine turbinate (BT) 
monolayers (appendix table 6). The initial washing medium was also 
assayed for active virus and subsequent washes were assayed only if 
the initial wash proved to be positive. Serum samples from each 
recipient were collected via jugular vein puncture at time of 
transfer and for 2 week intervals for 6 weeks. Sera were subjected 
to a microtitration virus-neutralization test (VNT) in order to 
quantitate BVD virus-neutralizing antibodies (Fulton et al., 1982; 
appendix table 10).
126
Plasma Samples and Progesterone Assay. Plasma samples were
obtained via jugular venipuncture of all recipients on the day of
transfer, three and fourteen days post-transfer for subsequent
progesterone analysis to verify luteal function. Blood was collected
32
in 15 ml heparinized vaccum tubes and chilled to 4 C immediately 
following collection. Samples were then centrifuged at 3000 rpm for 
ten minutes and the plasma pipetted into 7 ml plastic screw top vials 
for storage (-20 C) until analysis. The day 14 post-transfer 
sample corresponded to the approximate time of expected estrus, if 
pregnancy was not maintained, and was used to indicate pregnancy 
status early in gestation. Twice daily estrus detection was also 
utilized in order to obtain non-return rates.
Plasma progesterone levels were determined by a liquid- 
phase radioimmunoassay (Abraham et al., 1971). Progesterone was 
extracted from plasma with reagent grade petroleum ether and recon­
stituted in phosphate buffered saline (PBS-G). Aliquots of the 
reconstituted extracts were assayed with values corrected for percent 
recovery. Mean recovery of labelled progesterone from the plasma 
was 92.3 percent.
The highly specific progesterone anti-serum, kindly supplied 
by Dr. T. M. Nett of Colorado State University was diluted (1:2000) 
in .1 percent gelatin buffer prior to use. This same diluent was
■^Vacutainer (143 USP Units Sodium Heparin per 10 ml tube), 
Becton-Dickinson and Co., Rutherford, New Jersey.
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utilized in the preparation of the labelled progesterone (10,000 cpm/ 
200 yl) to formulate the standard curves.
Pregnancy Determination. Rectal aplpation of the uterus 
at 42 and 65 days post-transfer was utilized to determine pregnancy 
in experimental recipients. Recipients which had high progesterone 
levels at 14 days post-transfer (> 2 ng/ml) and extended estrous 
cycles after transfer of 5 days or greater than the mean of two 
previous estrous cycles prior to transfer were considered as having 
embryonic mortality.
Statistical Analysis. The pre- and post-culture morphological 
grade and fluorescence scores were determined at the onset and after 
24 hours of in vitro culture. Differences in these parameters between 
control and BVD virus-exposed embryos were analyzed by Student's 
t-test procedure (Steel and Torie, 1981). Chi-square analysis was 
utilized to test differences between control and BVD virus-exposed 
embryos during the culture period for result in development. Chi- 
square analysis was also used to test differences in 42 day and 65 
day pregnancy determination of control and BVD virus-exposed embryos. 
Plasma progesterone levels of the recipients on the day of transfer,
3 and 14 days post-transfer were compared by the general linear model 
procedure using a split-plot design with treatment as the main effect 
and interval (day of sampling) as the sub-unit (Goodnight, 1979). 
Duncan's Multiple Range Test was performed to determine differences 
due to treatment and interval means, while the least square means
128
were utilized for comparison of treatment means within an interval 
for progesterone levels.
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Results and Discussion 
Mean values for pre-culture and post-culture viability 
indicators and percent development are shown in table 23. Mean 
pre-culture grades for control and BVD virus-exposed embryos were 
similar and were not significantly different. In addition fluo­
rescence scores of embryos from each culture system were also similar. 
After culture for 24 h, control and BVD virus-exposed embryos were 
transferred through wash dilutions and reevaluated for grade and 
fluorescence. Post-culture grade assessment scores increased when 
compared to pre-culture scores indicating lowered viability, while 
post-culture fluorescence scores decreased verifying the indicated 
lowered viability obtained in the grade assessments. Post-culture 
evaluations for control and BVD virus-exposed embryos were not 
significantly different as to grade or fluorescence scores.
A total of 38 of 50 (76%) control medium-cultured embryos 
developed iri vitro while 36 of 50 (72%) of the BVD virus-exposed 
embryos showed positive in vitro development. Although more con­
trol embryos developed while in culture than BVD virus-exposed 
embryos, no significant difference was found for development between 
the two culture systems. Singh et al. (1982a) found similar results 
for in vitro embryonic development of embryos exposed to BVD virus.
Virus isolation assays confirmed active BVD virus in 
100 percent of BVD virus culture medium samples. The control cul­
ture medium and initial wash samples of each culture system were 
negative for BVD virus.
TABLE 23. MEAN VALUES FOR PRE-CULTURE AND POST-CULTURE VIABILITY INDICATORS 
AND PERCENT DEVELOPMENT OF CONTROL AND BVD VIRUS-EXPOSED EMBRYOS1
Pre-culture Post-culture No. of embryos
Culture system (n) Grade Fluorescence Grade Fluorescence developing in vitro % Developing
Control medium 50 1.61 2.75 1.66 1.16 38 76
±.n ±.i4 +.15 +.16
Control medium 50 1.46 3.00 1.86 1.12 36 72
+ BVD virus + .11 +.13 +.16 + .16
•^Student's t-test used to test differences among means. 
2
Mean plus or minus standard error.
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Serum samples from recipients transferred with control and 
BVD virus-exposed embryos were assayed for BVD antibody titers by 
serum neutralization techniques. In order to assess if seroconver­
sion occurred in recipients after transfer, samples were analyzed at 
transfer and for 2-week intervals for 6 weeks. Representative values 
of BVD serum antibodies for twenty recipients receiving control and 
BVD virus-exposed embryos are shown in table 24. No seroconversion 
was detected during the six week period following transfer in any 
recipient receiving either a control or BVD virus-exposed embryo.
From a total of 60 recipients, 28 females (46.6%) had positive serum 
antibody titers for BVD at the time of transfer. This percentage was 
lower than that previously reported for Louisiana cattle (Seger, 1968).
Plasma samples from all recipients were assayed for proges­
terone at three intervals to verify luteal function and to enable early 
pregnancy determination. Analysis of variance of plasma progesterone 
concentrations indicated significant variation due to interval, but 
treatment was not a source of significant variation. Figure 9 shows 
plasma progesterone concentrations of recipients transferred with 
control and BVD virus-exposed embryos at three intervals. Proges­
terone concentrations of recipients receiving control and BVD virus- 
exposed embryos on the day of transfer were not significantly dif­
ferent (5.81 vs 5.88 ng/ml) along with the mean day 3 post-transfer 
sample (8.26 vs 7.86 ng/ml). Mean progesterone concentrations of 
recipients of control embryos at 14 days post-transfer were higher than
TABLE 24. REPRESENTATIVE VALUES OF BVD SERUM ANTIBODIES OF RECIPIENTS 
NON-SURGICALLY TRANSFERRED WITH CONTROL OR BVD
VIRUS-EXPOSED EMBRYOS
BVD serum neutralization titers'^ "
Treatment Animal No.
2
Initial Second week Fourth week Sixth week
Control embryos 1 +; 1:2 1:2 +; 1:2 +; 1:2
2 +; 1:4 +; 1:2 +; 1:2 +; 1:4
3 +; 1:16 +; 1:8 +; 1:8 +; 1:16
4 -; 1:4 -; 1:4 -; 1:4 -; 1:4
5 -; 1:2 -S 1:2 -; 1:2 -; 1:2
6 +; 1:8 +; 1:4 +; 1:4 +; 1:8
7 -; 1:4 -; 1:4 -; 1:4 -; 1:4
8 -; 1:4 -; 1:4 -; 1:4 -; 1:4
9 +; 1:2 +; 1:2 +; 1:2 +; 1:2
10 -; 1:4 -; 1:4 -; 1:4 -; 1:4
BVD virus-exposed 11 -; 1:2 -; 1:2 -; 1:2 -; 1:2
embryos 12 -; 1:2 -; 1:2 -; 1:2 -; 1:2
13 +; 1:4 +; 1:4 +; 1:8 +; 1:4
14 +; 1:2 +; 1:2 -; 1:2 +; 1:2
15 -; 1:4 -; 1:4 -; 1:4 -; 1:4
16 +; 1:8 +; 1:8 +; 1:4 +; 1:8
17 +; 1:8 +; 1:4 +; 1:4 +; 1:4
18 -; 1:4 -; 1:4 -; 1:4 -; 1; 4
19 -; 1:4 -; 1:4 -; 1:4 -; 1:4
20 -; 1:4 -; 1:4 -; 1:4 -; 1:4
■'‘Titer indicates highest dilution at which neutralization occurred or the lowest dilution tested 
not exhibiting neutralization.
Serum sample taken at time of embryo transfer.
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Figure 9. Progesterone levels of control and BVD virus embryo 
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mean progesterone concentration of recipients of BVD virus-exposed 
embryos (4.31 vs 3.55 ng/ml), but the difference was not significant. 
The higher progesterone concentrations although not different 
(P > .05), gave an early indication that the control recipients could 
be expected to have a higher pregnancy rate than the recipients 
receiving BVD virus-exposed embryos.
Pregnancy was determined in experimental recipients at 42 
and 65 days post-transfer by rectal palpation (table 25). The number 
of 42-day pregnancies for recipients in control embryos was higher 
than that from recipients of BVD virus-exposed embryos, 8 of 30 
(26.7%) and 5 of 30 (16.7%), respectively. However, this difference 
in pregnancy rate was not significantly different. Determination of 
pregnancy at 65 days revealed embryonic losses when compared to the 
42-day pregnancy determination of the same recipients. Embryonic 
losses of recipients receiving control embryos (two pregnancies) 
were higher than that of recipients transferred with BVD virus-exposed 
embryos (one pregnancy). Existing 65-day pregnancies and percent 
pregnancy'rate for control embryos recipients were six and 20.0%, 
while the number of pregnancies and percent pregnancy rate of recip­
ients receiving BVD virus-exposed embryos was four (13.3%). The 
number of pregnancies for control and BVD virus cultured embryo 
transferred recipients were not significantly different at the 65 
day post-transfer pregnancy determination.
In order to explain the lower than normally expected preg­
nancy rate for non-surgically transferred embryos, attempts were made
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TABLE 25. PREGNANCY RATES OF RECIPIENTS NON-SURGICALLY 
TRANSFERRED WITH CONTROL AND BVD VIRUS- 
EXPOSED EMBRYOS
Treatment n
No. 42-day 
Pregnancies % Pregnant
No. 65-day 
Pregnancies % Pregnant
Control
embryos
30 8 26.7 6 20.0
BVD infected 
embryos
30 5 16.7 4 13.3
Pregnancy determined by rectal palpation.
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to characterize high progesterone concentrations at the 14-day post­
transfer sampling interval along with extended estrous cycles to 
reveal losses due to embryonic mortality in both control and BVD 
virus-exposed embryo transferred recipients. Table 26 shows the 
number of recipients transferred with embryos from each culture 
system for high progesterone (> 2 ng/ml), extended estrous cycles 
and embryonic mortality. More recipients from the BVD virus-exposed 
culture system had high progesterone concentrations at 14 days post­
transfer and extended estrous cycles than control embryo transferred 
recipients. Embryonic mortality, defined as the combination of high 
progesterone concentrations at 14 days post-transfer and estrous 
cycles extended greater than 5 days than the mean previous pre-trans­
fer estrous, was higher in BVD exposed embryo transferred recipients 
(5 of 30; 16.7%) than in control embryo transferred recipients (3 of 
30; 10%). However, this difference was not statistically signifi­
cant. These embryonic losses may be accounted for by the high 
environmental temperatures and humidity that recipients were sub­
jected to during the process of the experiment. Ulberg and Burfening 
(1967) have supportive data showing that high air temperature caused 
a reduced reproductive rate because of increased embryonic death 
rate. However, because of the small number of pregnancies obtained 
in the present experiment, no conclusive statement can be made regar­
ding the effect of the BVD virus on early embryonic mortality.
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TABLE 26. PLASMA PROGESTERONE CONCENTRATIONS, EXTENDED ESTROUS CYCLES 
AND EMBRYONIC MORTALITY OF RECIPIENTS TRANSFERRED 
WITH CONTROL AND BVD-EXPOSED EMBRYOS
Control embryos BVD-virus exposed embryos
Variables No. recipients % No. recipients %
1
High progesterone 14 46.7 16 53.3
2
Extended cycles 5 16.7 6 20.0
3
Embryonic mortality 3 10.0 5 16.7
Progesterone levels > 2 ng/ml plasma at 14 days post-transfer.
2
Estrous cycle extended greater than 5 days than previous pre­
transfer estrous cycles.
3
Progesterone levels > 2 ng/ml at 14 days post-transfer and 
extended estrous cycles post-transfer of 5 days or greater than 
mean estrous cycles prior to transfer.
SUMMARY AND CONCLUSIONS
Data from a total of 402 bovine preimplantation embryos were 
used to develop new techniques for estimating bovine embryo viability 
and to investigate the effect of the virus of Bovine Viral Diarrhea 
(BVD) on in vitro culture and subsequent embryo development.
A preliminary study (Chapter I) was conducted in order to 
evaluate the use of fluorescein diacetate (FDA) to assess viability 
of bovine embryos in vitro. The evaluation of viability with FDA 
was more sensitive than morphological grading assessments in its 
ability to establish positive development in vitro of bovine embryos. 
Although both viability indicators were highly correlated at both 
pre-culture and post-culture evaluations, the more biologically 
sensitive FDA test has the advantage of measuring both intercellular 
enzyme activity and membrane integrity. The FDA test was found to 
be easily adapted to the general technique of embryo transfer and 
was determined to be a useful aid in complementing morphological 
grading techniques in accessing viability of bovine embryos iri vitro.
In Chapter II, live and dead embryos were exposed to BVD 
virus in an in vitro culture system in an attempt to evaluate the 
zona pellucida's ability to protect the developing embryo from BVD 
virus particle penetration. In vitro development was similar for 
live embryos with and without the zona pellucida, indicating that 
embryonic development was independent of the intact zona pellucida.
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Viral isolation analysis of sonificated virus-exposed embryos proved 
negative, along with attempts to quantitate the uptake of virus.
Due to some inefficiencies involved with conventional viral assays 
and the small size of bovine embryos, further analysis was employed 
utilizing transmission electron microscopy (TEM). TEM revealed struc­
tures in both live embryos with and without a zona pellucida, which 
morphologically resembled the BVD virus. The presence of these 
"virus-like" particles indicated that the BVD virus can penetrate 
the intact zona pellucida. TEM evaluation of dead embryos both with 
and without a zona pellucida showed vast cytoplasmic degeneration 
and no "virus-like" particles that resembled BVD was observed.
Micro-injection of BVD virus, via micromanipulation (Chapter 
III), directly into the blastocoelic cavity by piercing the zona 
pellucida, vitelline and trophoblastic membranes of bovine blasto­
cysts had no detrimental effect on in vitro development. Further­
more, blastocysts injected with BVD virus developed at a rate of 
91.67 percent, which was higher than injected and non-injected con­
trol blastocysts. These results support those of Chapter II, when 
embryos were exposed to BVD and no subsequent lowered development 
was observed. Previous research has indicated that the BVD virus 
could inhibit mitosis of several mammalian cell types both iri vitro 
and jin vivo, although development of BVD-exposed embryos was not 
effected. The possibility that the virus was rendered non-infective 
upon interaction with the embryos, or that early bovine embryos may 
not be susceptible to BVD virus jin vitro cannot be distinguished in
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this study. Although somatic cells are permissive for BVD virus, the 
possibility for non-permissiveness of embryos to infection has been 
reported.
In an attempt to utilize embryo transfer as a means of 
studying viral infection and to provide evidence that embryo trans­
fer can be used in a disease prevention manner, experimentation in 
Chapter IV was developed. One hundred bovine embryos cultured in 
a control medium without BVD virus and a virus-infected medium 
were evaluated initially for in vitro development and subsequently 
non-surgically transferred to suitable recipients. Control embryos 
developed at a higher, but non-significant rate, than BVD virus- 
exposed embryos. Also, pregnancy rates were higher for control 
embryos than for BVD virus-exposed embryos. However these dif­
ferences were not statistically significant. Serological status 
of recipients receiving control and BVD virus-exposed embryos did 
not change over a six week post-transfer period, indicating either 
that the BVD virus was not transmitted by the exposed embryos or 
-medium, or that if virus was transmitted by the transfer technique 
the level was below the immunological threshold of the recipients.
The fact that pregnancies were established from embryos exposed to 
BVD virus suggests that embryo transfer may be useful in controlling 
the disease in infected or seropositive donor cattle. However, to 
ultimately answer this question the pregnancy rate following transfer 
of embryos micro-injected with BVD virus to Seronegative and Sero­
positive recipients must be ascertained.
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APPENDIX TABLE 1. EMBRYO MORPHOLOGICAL STAGES NORMALLY
FOUND ON SPECIFIC DAYS OF THE 
ESTROUS CYCLE3
Morphological Description Days after estrus normally found
1 -cell 0 - 1
2 -cell 1- 3
4-cell 2- 3
8 -cell 3- 5
16-cell 4- 5
Morula 5- 6
Tight Morula 5- 7
Early Blastocyst 7- 8
Blastocyst 7- 9
Expanded Blastocyst 8 - 1 0
Hatching Blastocyst 9-11
aSeidel et al. (1980)
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APPENDIX TABLE 2. COMPONENTS OF DULBECCO'S PBS MEDIUM
FOR NON-SURGICAL BOVINE EMBRYO 
COLLECTION PROCEDURE
Component gms/ 1
CaCl2 0 . 1 0
KCL 0 . 2 0
MgS04 -7H20 0 . 1 0
NaCl 8 . 0 0
kh2 po4 0 . 2 0
NaH2 P 0 4 -H2 0 2.16
Special Components
Fetal Calf Seruml 2  ml / 1 0 0  ml
Penicillin 100 IU/ml
Streptomycin 1 0 0  ug/ml
Fungizone .25 ug/ml
Heat inactivated, virus screened and mycoplasma 
tested.
APPENDIX TABLE 3. COMPONENTS OF DULBECCO'S PBS FOR
CULTURE MEDIUM USED IN FDA 
VIABILITY TEST PROCEDURE*
Component gms/ 1
CaCl2 0 . 1 0
KC1 0 . 2 0
MgS04 -7H20 0 . 1 0
NaCl 8 . 0 0
kh 2 po4 0 . 2 0
NaH P0.-H„0 
2  4 2
2.16
Special Components
Fetal Calf Serum^ 2 0  ml / 1 0 0  ml
Penicillin 100 IU/100 ml
Steptomycin 1 0 0  ug / 1 0 0  ml
Fungizone .25 ug/100 ml
^Filtered through .22 pm millipore filter.
2
Heat inactivated, virus screened, mycoplasma 
tested.
APPENDIX TABLE 4. CONSTITUENTS OF COMPLETE MEDIUM FOR
CULTURE OF BOVINE EMBRYOS WITH BVD 
VIRUS
Dulbecco's Phosphate Buffered Saline (PBS)
Component gms/ 1
CaCl2 . 1 0
KC1 . 2 0
MgS04 -7H20 . 1 0
NaCl 8 . 0 0
kh2 po4 . 2 0
NaH2 P0 4 -H2 0 2.16
Modified Minimum Essential Medium (MEM) 
with Earle's Salts
Component mg / 1
CaCl2 2 0 0 . 0 0
KC1 400.00
MgS04 (anhyd.) 97.67
NaCl 6800.00
NaH2 P04 -H20 140.00
D-Glucose 1 0 0 0 . 0 0
Phenol red 1 0 . 0 0
L-alanine 8.90
L-arginine-HCl 126.00
L-asparagine-H20 15.00
L-aspartic Acid 13.30
L-cystine-2 HC1 31.29
L-glutamic acid 14.70
L-glutamine 292.00
Glycine 7.50
L-histidine HC1-H20 42.00
L-isoleucine 52.00
L-leucine 52.00
L-lysine HC1 72.50
L-methionine 15.00
L-phenylalanine 32.00
L-proline 11.50
L-serine 10.50
L-threonine 48.00
L-tryptophane 1 0 . 0 0
L-tyrosine (disodium salt) 52.10
APPENDIX TABLE 4. (Continuation)
MEM with Earle's Salts
Component mg/i
L-valine 46.00
D-Ca pantothenate 1 . 0 0
Choline chloride 1 . 0 0
Folic acid 1 . 0 0
i-inositol 2 . 0 0
Nicotinamide 1 . 0 0
Pyridoxal HC1 1 . 0 0
Riboflavin . 1 0
Thiamine HC1 1 . 0 0
LSU Virology Lab Modification of MEM:
.01N NaHC03  in 1 1
.01N NaOH in 1 1
.025 M 4-(2-hydroxyethyl)-l-piperazin<
ethande sulphanic acid (HEPES)
(Preparatory Instructions)
Mixture of PBS and MEM 1:1
Addition of 10% heat inactivated goat serum (V/V)
Addition of 100 IU Pennicillin, 100 yg Streptomycin,
.25 yg Fungizone/ml
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APPENDIX TABLE 5. LABORATORY PROCEDURES FOR TRANSMISSION
ELECTRON MICROSCOPY OF BOVINE EMBRYOS
Procedure Description of procedure
1. Pre-fixation
2. Wash
3. Post-fixation
4. Wash
5. Dehydration
6 . Infiltration
7. Polymerization
8 . Sectioning ,
9. Section staining
10. Grid Evaluation
Transfer embryos to 3% glutarald- 
hyde in .1M sodium phosphate 
buffer (7.4 pH; 490 mOsm) for 
1  hour.
Transfer embryos to three conse­
cutive wash solutions of .1M 
sodium phosphate buffer at 15 
minute intervals.
Transfer embryos to 1% osmium 
tetroxide in .1M sodium phosphate 
buffer (7.4 pH) for 1 hour. 
Transfer embryos to three conse­
cutive wash solutions of .1M 
sodium phosphate buffer at 15 
minute intervals.
Transfer embryos to ethanol 
concentrations in series of 60%, 
70%, 80%, 90%, 90%, 100%, 100%, 
100% for 15 minutes each.
Addition of approximately .5-lml 
epon embedding plastic to 2-3ml 
1 0 0 % ethanol containing the 
embryos.
Single embryos are transferred 
to pure epon contained in 7ml 
plastic weigh boats and held 
at 50°C for 72 hours.
Embryos are sectioned with 
Sorvall ultramicrotome equipped 
with a diamond knife at a thick­
ness of 1 0 0  X, and five to ten 
sections transferred to 2 0 0  
mesh grids.
Thin section were stained with 
uranyl acetate and lead citrate 
each for 1 0 - 2 0  minutes.
Grids were examined using a Zeiss- 
10 TEM at various magnifications.
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APPENDIX TABLE 6 . LABORATORY PROCEDURE FOR VIRUS .
ISOLATION IN MONOLAYER CELL 
CULTURES3
Medium Used: Minimum Essential Medium (MEM) with 10% Goat
Serum (GS) with 200 IU Pennicillin, 200 yg 
Streptomycin and .50 yg Fungizone/ml.
Tissue Culture System: Bovine turbinate (BT) monolayers
in 24 well flat bottom sterile 
tissue culture plates.
Procedure No. Description of procedure
1. Two wells per sample are seeded with
5.
4.
3.
2 .
a constant suspension of BT cells. 
Each of two wells received .5ml of 
prepared sample.
Virus isolation plates incubated in a 
humidified air atmosphere at 37C.
Each well will be read for cytopathic 
effects (CPE) once daily through 
inverted microscope with final 
reading for CPE made seven days post 
infection.
Uninfected control wells serve as a 
cell control on each plate.
aFulton, R. W., W. T. Springer, H. V. Hagstad, S. S. Nicholson, 
N. J. Pearson, M. M. Downing and M. T. Potter, 1982. IBR virus and 
PI^ virus in nasal flora of dairy calves. Bovine Practioner 17:59.
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APPENDIX TABLE
Procedure
1. Conjugation of
2. Direct Method
7. LABORATORY PROCEDURES FOR FLUORESCENT 
ANTIBODY (FA) STAINING
Description of procedure
immunoglobulin Immunoglobulin to BVD virus
is separated from serum and 
concentrated and combined 
chemically with a stable 
fluorescent dye. The labeled 
antibody is used to detect 
the specific antigen (BVD 
virus).
Specific antibody with fluo­
rescent dye obtained from 
U.S.D.A. N.V.S.L., Ames,
Iowa, was allowed to react 
with suspected viral con­
taminated samples. A positive 
reaction with antibody and 
antigen (BVD virus) results 
in a brillant glow when 
observed under fluorescent 
microscopy.
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APPENDIX TABLE 8 . LABORATORY PROCEDURES FOR
TITRATION OF VIRUS
Definition: A virus titration is a quantitative
determination of viral activity, i.e., 
the smallest amount of viral suspension 
which can produce disease, lesions, or 
some recognizable effect in the host.
Procedure
1. Preparation of serial dilutions
2. Cell controls
3. Incubation
4. CPE observation
5. Calculation of virus titers
Description of procedure
Ten fold dilutions of BVD 
virus suspensions in MEM 
over an indicator system 
of Ovine Fetal Turbinate 
(OFT) cells in 96 well 
plates.
Uninfected control wells 
serve as a cell control 
on each plate.
Plates are incubated in a 
humidified air atmosphere at 
37C.
Each well of the titration 
plate are observed each 
day for seven days.
Titers are expressed as the 
reciprocal of the highest 
dilution of the virus, which 
are expressed as the 50% 
tissue culture infective dose
(tc i d5Q).
APPENDIX TABLE 9. COMPONENTS OF HAM'S F-10 FOR
CULTURE MEDIUM USED IN MICRO 
INJECTION PROCEDURE1
Components mg/1
Inorganic salts
CaCl2 -2H20 44.1
CuS04 ’5H20 .0025
FeSO^•7H20 .834
KC1 285.0
KH2 P04  83.0
MgS04*7H20 152.8
NaCl 7400.0
NaHC03  1200.0
NaHPO^•7H20 290.0
ZNSO4 •7H20 .0288
Other Components
Glucose 1100.0
Hypoxanthine 4.0
Lipoic acid .2
Phenol red 1.2
Sodium pyruvate 110.0
Thymidine .7
Amino acids
L-alanine 9.0
L-arginine HC1 211.0
L-asparagine H20 15.01
L-aspartic acid 13.0
L-cysteine 25.0
L-glutamic acid 14.7
L-glutamine 146.0
Glycine 7.51
L-histidine HC1-H20 23.0
L-isoleucine 2.6
L-leucine 13.0
L-lysine HC1 29.0
L-methionine 4.48
L-phenylalanine 5.0
L-proline 11.5
L-serine 10.5
L-threonine 3.57
L-tryptophan .6
L-tyrosine 1.81
L-valine 3.5
APPENDIX TABLE 9. (Continuation)
Components mg/i
Vitamins
Biotin .024
D-Ca pantothenate .175
Choline chloride .698
Folic acid 1.320
i-inositol .541
Niacinamide .615
Pyridoxine HC1 .206
Riboflavin .376
Thiamine HCl 1 . 0 0 0
Vitamin Bj^ 1.360
Special Components
Fetal calf serum^ 1 0  ml / 1 0 0  ml
Penicillin 100 IU/ml
Streptomycin 1 0 0  yg/ml
Fungizone .25 yg/ml
"''Filtered through .22 ym millipore filter.
^Heat inactivated, virus screened, mycoplasma 
tested.
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APPENDIX TABLE 10. LABORATORY PROCEDURES FOR SEROLOGIC
TESTING FOR BVD VIRUS NEUTRALIZING 
ANTIBODIES
Tissue culture system: Ovine fetal turbinate (OFT) monolayers 
in 96-well microtitration plates
Beta Neutralization: 100 TCID^ of BVD Singer Strain was
incubated with two-fold serum dilutions.
Procedure No. 
1 .
2 .
3.
Description of procedure
Serum was heat inactivated at 56 C for 
30 seconds.
.25 ml MEM medium with antibotics was 
added to each well.
Undiluted serum (.05 ml) was added to 
the first well and serial 2 -fold dilution 
were made with sterile microdiluting 
loops (. 5 ml).
TCID^q /,025 ml) was added to each serum 
dilution.
Plates were agitated and incubated for 
1  hour at room temperature.
Dispersed OFT cells (.05 ml) was added 
to each well and incubated at 37 C for 
7 days.
Virus neutralizing titers (VNT) were 
expressed as the final dilution of 
serum that completely inhibited viral 
CPE in duplicate wells.
For each sera tested (four sera per 
recipient), serum and virus controls 
were included along with a cell control 
well. Also included were proven posi­
tive or negative sera.
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